<?xml version='1.0' encoding='UTF-8'?>
<chapter id="ch0040">
    <title>24 Aerococcus, Abiotrophia, and Other Aerobic Catalase-Negative, Gram-Positive Cocci</title>
    <sect1 id="ch0040s0001">
      <title>24 Aerococcus, Abiotrophia, and Other Aerobic Catalase-Negative, Gram-Positive Cocci</title>
      <anchor id="ch0040s0001a0001"/>
      <anchor id="ch0040s0001a0002"/>
      <para role="chapterAuthor"><phrase role="center">XIAOHUI CHEN NIELSEN AND JENS JØRGEN CHRISTENSEN</phrase>
      </para>
      <sect2 id="ch0040s0001s0001">
        <title>TAXONOMY</title>
        <anchor id="ch0040s0001s0001a0001"/>
        <anchor id="ch0040s0001s0001a0002"/>
        <para id="ch0040s0001s0001p0001">The catalase-negative, Gram-positive cocci included in this chapter form a taxonomically diverse group of bacteria that are isolated infrequently as opportunistic agents of infection. Most of these organisms resemble other, better-known clinical isolates (i.e., streptococci and enterococci) and consequently may be mistaken for members of those genera. Although probably misidentified or overlooked in clinical cultures in the past, these organisms may represent emerging pathogens in immunocompromised patient populations.<anchor id="ch0040s0001s0001a0003"/><link linkend="ch0040s0001s0001a0005">Table 1</link> lists the organisms included here, along with some of their basic characteristics. The bacteria discussed in this chapter are members of the phylum <emphasis>Firmicutes</emphasis> (low-G+C, Gram-positive bacteria). Except for the genera <emphasis>Helcococcus</emphasis> (class <emphasis>Clostridia</emphasis>) and <emphasis>Gemella</emphasis> (order <emphasis>Bacillales</emphasis>), these genera are classified in the class <emphasis>Bacilli</emphasis> and in the order <emphasis>Lactobacillales</emphasis> (<link linkend="ch0040s0018s0007li0001">1</link>, <link linkend="ch0040s0018s0007li0002">2</link>). The order <emphasis>Lactobacillales</emphasis> encompasses the families <emphasis>Aerococcaceae, Carnobacteriaceae, Enterococcaceae, Lactobacillaceae, Leuconostocaceae</emphasis>, and <emphasis>Streptococcaceae</emphasis>. Genera mentioned in this chapter belonging to these families are <emphasis>Aerococcus, Abiotrophia</emphasis>, and <emphasis>Facklamia</emphasis> and the so-called minor genera <emphasis>Dolosicoccus, Eremococcus, Globicatella</emphasis>, and <emphasis>Ignavigranum</emphasis> (in the <emphasis>Aerococcaceae</emphasis>), <emphasis>Alloiococcus, Dolosigranulum</emphasis>, and <emphasis>Granulicatella</emphasis> (in the <emphasis>Carnobacteriaceae</emphasis>), <emphasis>Tetragenococcus</emphasis> and <emphasis>Vagococcus</emphasis> (in the <emphasis>Enterococcaceae</emphasis>), <emphasis>Pediococcus</emphasis> (in the <emphasis>Lactobacillaceae</emphasis>), <emphasis>Leuconostoc</emphasis> and <emphasis>Weissella</emphasis> (in the <emphasis>Leuconostocaceae</emphasis>), and <emphasis>Lactococcus</emphasis> (in the <emphasis>Streptococcaceae</emphasis>). See <ulink url="ch0037#ch0037s0001">chapter 21</ulink> for information on <emphasis>Rothia mucilaginosa</emphasis>, another infrequently isolated Gram-positive coccus that may be catalase negative.</para>
        <para id="ch0040s0001s0001p0002">The genus<emphasis>Lactococcus</emphasis> is composed of organisms formerly classified as Lancefield group N streptococci (<link linkend="ch0040s0018s0007li0003">3</link>). The species <emphasis>Lactococcus lactis</emphasis> and <emphasis>Lactococcus garvieae</emphasis> have been documented in human infections. Motile <emphasis>Lactococcus</emphasis>-like organisms with the Lancefield group N antigen (a teichoic acid antigen) are classified in the genus <emphasis>Vagococcus</emphasis> (<link linkend="ch0040s0018s0007li0004">4</link>). <emphasis>Vagococcus fluvialis</emphasis> has been isolated from human blood culture, wounds, peritoneal fluid, cerebrospinal fluid, and root canal (<link linkend="ch0040s0018s0007li0005">5</link>). A newly described species, <emphasis>Vagococcus vulneris</emphasis>, was isolated from a human foot wound (<link linkend="ch0040s0018s0007li0006">6</link>). The vagococci also resemble the enterococci, as noted by Facklam and Elliott (<link linkend="ch0040s0018s0007li0007">7</link>).</para>
        <para id="ch0040s0001s0001p0003">The genera<emphasis>Abiotrophia</emphasis> and <emphasis>Granulicatella</emphasis> include organisms previously known as nutritionally variant or satelliting streptococci (<link linkend="ch0040s0018s0007li0008">8</link>, <link linkend="ch0040s0018s0007li0009">9</link>). These bacteria were originally thought to be nutritional mutants of viridans group streptococcal strains, most notably of the species <emphasis>Streptococcus mitis</emphasis>. A comparative analysis of 16S rRNA gene sequences led Kawamura and coworkers to propose the creation of a new genus, <emphasis>Abiotrophia</emphasis>, containing two species, <emphasis>Abiotrophia defectiva</emphasis> and <emphasis>Abiotrophia adiacens</emphasis>, to accommodate these bacteria (<link linkend="ch0040s0018s0007li0009">9</link>). A third species from human sources, <emphasis>Abiotrophia elegans</emphasis>, was described in 1998 (<link linkend="ch0040s0018s0007li0010">10</link>). In 2000, Collins and Lawson proposed a new genus, <emphasis>Granulicatella</emphasis>, with <emphasis>Granulicatella adiacens</emphasis> and <emphasis>Granulicatella elegans</emphasis> representing strains formerly called <emphasis>A. adiacens</emphasis> and <emphasis>A. elegans</emphasis>. <emphasis>A. defectiva</emphasis> remains as the sole <emphasis>Abiotrophia</emphasis> species (<link linkend="ch0040s0018s0007li0008">8</link>).</para>
        <para id="ch0040s0001s0001p0004">Among the intrinsically vancomycin-resistant, catalase-negative, Gram-positive cocci, a number of<emphasis>Leuconostoc</emphasis> species have been noted in human infection (<emphasis>Leuconostoc mesenteroides, Leuconostoc lactis, Leuconostoc pseudomesenteroides</emphasis>, and <emphasis>Leuconostoc citreum</emphasis> [11]). In 1993, the former <emphasis>Leuconostoc paramesenteroides</emphasis> and related species were placed into a novel genus, <emphasis>Weissella</emphasis> (<link linkend="ch0040s0018s0007li0012">12</link>). Twenty-four species of <emphasis>Weissella</emphasis> have been recognized and validly published (<ulink url="https://lpsn.dsmz.de/genus/weissella">https://lpsn.dsmz.de/genus/weissella</ulink>; accessed 30 December 2021); however, only three have been detected in human specimens: <emphasis>Weissella confusa, W. cibaria</emphasis>, and <emphasis>W. viridescens</emphasis> (<link linkend="ch0040s0018s0007li0013">13</link>). <emphasis>Pediococcus acidilactici</emphasis> and <emphasis>Pediococcus pentosaceus</emphasis> are the most common clinical isolates of pediococci (<link linkend="ch0040s0018s0007li0014">14</link>). The vancomycin-susceptible species formerly named <emphasis>Pediococcus halophilus</emphasis> was reclassified in the genus <emphasis>Tetragenococcus</emphasis> (<link linkend="ch0040s0018s0007li0015">15</link>). The organism formerly called <emphasis>Enterococcus solitarius</emphasis> has also been transferred to the genus <emphasis>Tetragenococcus</emphasis> as <emphasis>Tetragenococcus solitarius (</emphasis>16<emphasis>)</emphasis>. <emphasis>Tetragenococcus</emphasis> is known to contribute to food fermentation; however, little is known about the role of the tetragenococci in human infection.</para>
        <para id="ch0040s0001s0001p0005">The organism we now know as<emphasis>Gemella morbillorum</emphasis> was described as <emphasis>Diplococcus rubeolae</emphasis> in 1917 by Tunnicliff (<link linkend="ch0040s0018s0007li0017">17</link>) as isolates from the blood of patients with measles. Later, <emphasis>G. morbillorum</emphasis> was named <emphasis>Peptostreptococcus morbillorum</emphasis> and <emphasis>Streptococcus morbillorum</emphasis> until a proposal to include it in the genus <emphasis>Gemella</emphasis> as <emphasis>G. morbillorum</emphasis> was made in 1988 (<link linkend="ch0040s0018s0007li0018">18</link>). A second species, <emphasis>Gemella haemolysans</emphasis>, was originally classified as a <emphasis>Neisseria</emphasis> species, due to its Gram-variable or even Gram-negative nature and its cellular morphology (diplococci with flattened adjacent sides). Collins and coworkers described two additional <emphasis>Gemella</emphasis> species isolated from human sources, <emphasis>Gemella bergeri</emphasis> (originally named <emphasis>Gemella bergeriae</emphasis> [19]) and <emphasis>Gemella sanguinis</emphasis> (<link linkend="ch0040s0018s0007li0020">20</link>). Three other species, <emphasis>Gemella asaccharolytica</emphasis> (<link linkend="ch0040s0018s0007li0021">21</link>), <emphasis>Gemella parahaemolysans,</emphasis> and <emphasis>Gemella taiwanensis</emphasis> (<link linkend="ch0040s0018s0007li0022">22</link>)<emphasis>,</emphasis> were also isolated from human clinical specimens. The genus <emphasis>Dolosigranulum,</emphasis> with its single species <emphasis>Dolosigranulum pigrum,</emphasis> shows phenotypic similarities to <emphasis>Gemella</emphasis>, although it is not phylogenetically closely related to <emphasis>Gemella</emphasis> strains (<link linkend="ch0040s0018s0007li0023">23</link>, <link linkend="ch0040s0018s0007li0024">24</link>).</para>
        <anchor id="ch0040s0001s0001a0004"/>
        <beginpage pagenum="471"/>
        <table id="ch0040s0001s0001t0001"><title><emphasis role="strong"><phrase role="figureLabel"><anchor id="ch0040s0001s0001a0005"/><link linkend="ch0040s0001s0001a0003">TABLE 1</link></phrase></emphasis> Possible identities of catalase-negative, Gram-positive cocci based on certain phenotypic reactions and cellular morphology<superscript><emphasis><anchor id="ch0040s0001s0001a0006"/><link linkend="ch0040s0001s0001a0018">a</link></emphasis></superscript>
</title>
          
          <tgroup cols="5">
            <tbody>
              <row>
                <entry><phrase role="center">Phenotypic reaction</phrase>
                </entry>
                <entry><phrase role="center">Organism(s) with cellular morphology</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="center">PYR</phrase>
                </entry>
                <entry><phrase role="center">LAP</phrase>
                </entry>
                <entry><phrase role="center">NaCl</phrase>
                </entry>
                <entry><phrase role="center">Pairs or chains</phrase>
                </entry>
                <entry><phrase role="center">Clusters, tetrads, or irregular groups</phrase>
                </entry>
              </row>
              <row>
                <entry>+</entry>
                <entry>+</entry>
                <entry>+</entry>
                <entry><emphasis>Enterococcus</emphasis>,<superscript><emphasis><anchor id="ch0040s0001s0001a0007"/><link linkend="ch0040s0001s0001a0019">b</link>,</emphasis></superscript><superscript><emphasis><anchor id="ch0040s0001s0001a0008"/><link linkend="ch0040s0001s0001a0020">c</link>,<anchor id="ch0040s0001s0001a0009"/><link linkend="ch0040s0001s0001a0021">d</link></emphasis></superscript> <emphasis>Vagococcus</emphasis>,<superscript><emphasis><link linkend="ch0040s0001s0001a0020">c</link></emphasis></superscript><superscript><emphasis>,</emphasis></superscript><superscript><emphasis><anchor id="ch0040s0001s0001a0010"/><link linkend="ch0040s0001s0001a0022">e</link></emphasis></superscript> <emphasis>Lactococcus</emphasis>,<superscript><emphasis><link linkend="ch0040s0001s0001a0021">d</link></emphasis></superscript> <emphasis>Facklamia</emphasis> spp. other than <emphasis>F. languida, Ignavigranum</emphasis><superscript><emphasis><anchor id="ch0040s0001s0001a0011"/><link linkend="ch0040s0001s0001a0023">f</link></emphasis></superscript></entry>
                <entry><emphasis>Facklamia languida, Dolosigranulum, Aerococcus sanguinicola</emphasis>
                </entry>
              </row>
              <row>
                <entry>+</entry>
                <entry>+</entry>
                <entry>−</entry>
                <entry><emphasis>Abiotrophia</emphasis>,<superscript><emphasis><anchor id="ch0040s0001s0001a0012"/><link linkend="ch0040s0001s0001a0024">g</link></emphasis></superscript> <emphasis>Granulicatella</emphasis>,<superscript><emphasis><link linkend="ch0040s0001s0001a0024">g</link></emphasis></superscript> <emphasis>Gemella</emphasis> spp. other than <emphasis>G. haemolysans</emphasis> and <emphasis>G. asaccharolytica</emphasis></entry>
                <entry><emphasis>G. haemolysans</emphasis> (cells arranged primarily in pairs with adjacent sides flattened)<superscript><emphasis><anchor id="ch0040s0001s0001a0013"/><link linkend="ch0040s0001s0001a0025">h</link></emphasis></superscript></entry>
              </row>
              <row>
                <entry>+</entry>
                <entry>−</entry>
                <entry>+</entry>
                <entry><emphasis>Globicatella</emphasis>
                </entry>
                <entry><emphasis>Aerococcus viridans</emphasis>,<superscript><emphasis><link linkend="ch0040s0001s0001a0025">h</link></emphasis></superscript> <emphasis>Helcococcus kunzii</emphasis><superscript><emphasis><anchor id="ch0040s0001s0001a0014"/><link linkend="ch0040s0001s0001a0026">i</link></emphasis></superscript></entry>
              </row>
              <row>
                <entry>+</entry>
                <entry>−</entry>
                <entry>−</entry>
                <entry><emphasis>Dolosicoccus</emphasis>
                </entry>
                <entry></entry>
              </row>
              <row>
                <entry>−</entry>
                <entry>+</entry>
                <entry>+</entry>
                <entry></entry>
                <entry><emphasis>Aerococcus urinae, Pediococcus</emphasis>,<superscript><emphasis><anchor id="ch0040s0001s0001a0015"/><link linkend="ch0040s0001s0001a0028">k</link></emphasis></superscript> <emphasis>Tetragenococcus</emphasis></entry>
              </row>
              <row>
                <entry>−</entry>
                <entry>+</entry>
                <entry>−</entry>
                <entry>Viridans group streptococci,<superscript><emphasis><anchor id="ch0040s0001s0001a0016"/><link linkend="ch0040s0001s0001a0029">l</link></emphasis></superscript> <emphasis>G. asaccharolytica</emphasis> (Gram variable)</entry>
                <entry></entry>
              </row>
              <row>
                <entry>−</entry>
                <entry>−</entry>
                <entry>+</entry>
                <entry><emphasis>Leuconostoc</emphasis>,<superscript><emphasis><anchor id="ch0040s0001s0001a0017"/><link linkend="ch0040s0001s0001a0027">j</link></emphasis></superscript> <emphasis>Weissella</emphasis><superscript><emphasis><link linkend="ch0040s0001s0001a0028">k</link></emphasis></superscript></entry>
                <entry></entry>
              </row>
            </tbody>
          </tgroup>
        </table>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0040s0001s0001a0018"/><link linkend="ch0040s0001s0001a0006">a</link></emphasis></superscript>Abbreviations and symbols: PYR, production of pyrrolidonyl arylamidase; LAP, production of leucine aminopeptidase; NaCl, growth in 6.5% NaCl; +, ≥90% of strains positive; −, ≤10% of strains positive.</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0040s0001s0001a0019"/><link linkend="ch0040s0001s0001a0007">b</link></emphasis></superscript>Some strains may display vancomycin resistance; some strains are motile.</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0040s0001s0001a0020"/><link linkend="ch0040s0001s0001a0008">c</link></emphasis></superscript>Most enterococcal strains are capable of growth at 45°C, differentiating them from vagococci, which may be phenotypically similar. Strains of vagococci have been reported as testing positive with a commercially available nucleic acid probe for members of the genus <emphasis>Enterococcus</emphasis>.</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0040s0001s0001a0021"/><link linkend="ch0040s0001s0001a0009">d</link></emphasis></superscript>Phenotypically similar strains of enterococci and lactococci can be differentiated with a commercially available nucleic acid probe for members of the genus <emphasis>Enterococcus</emphasis>.</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0040s0001s0001a0022"/><link linkend="ch0040s0001s0001a0010">e</link></emphasis></superscript>Motile.</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0040s0001s0001a0023"/><link linkend="ch0040s0001s0001a0011">f</link></emphasis></superscript>Some strains display satelliting growth; some strains are urease positive.</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0040s0001s0001a0024"/><link linkend="ch0040s0001s0001a0012">g</link></emphasis></superscript>Members of this genus display satelliting growth.</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0040s0001s0001a0025"/><link linkend="ch0040s0001s0001a0013">h</link></emphasis></superscript>Two additional <emphasis>Gemella</emphasis> species, <emphasis>Gemella parahaemolysans</emphasis> and <emphasis>Gemella taiwanensis</emphasis>, are described as resembling <emphasis>G. haemolysans</emphasis>. See reference <link linkend="ch0040s0018s0007li0022">22</link> for details.</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0040s0001s0001a0026"/><link linkend="ch0040s0001s0001a0014">i</link></emphasis></superscript>Although <emphasis>H. kunzii</emphasis> shares some phenotypic traits with <emphasis>A. viridans</emphasis>, it is facultative and usually nonhemolytic, in contrast to <emphasis>A. viridans</emphasis>, which prefers an aerobic growth atmosphere and is alpha-hemolytic.</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0040s0001s0001a0027"/><link linkend="ch0040s0001s0001a0017">j</link></emphasis></superscript>One additional species of <emphasis>Helcococcus, H. sueciensis,</emphasis> displays negative reactions in the PYR test, in contrast to <emphasis>H. kunzii</emphasis>.</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0040s0001s0001a0028"/><link linkend="ch0040s0001s0001a0015">k</link></emphasis></superscript>Vancomycin resistant.</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0040s0001s0001a0029"/><link linkend="ch0040s0001s0001a0016">l</link></emphasis></superscript>Viridans group streptococci include streptococci of the anginosus, mitis, mutans, salivarius, and equinus (previously bovis) species groups. Some strains of <emphasis>Streptococcus pneumoniae</emphasis> (a member of the mitis species group) may produce positive reactions in the PYR test.</para>
        <para id="ch0040s0001s0001p0006"><emphasis>Aerococcus urinae</emphasis>, described in 1992, is negative for pyrrolidonyl arylamidase production (PYR) and positive for leucine aminopeptidase production (LAP), showing reactions opposite those of <emphasis>Aerococcus viridans</emphasis> in these important identification tests (<link linkend="ch0040s0018s0007li0025">25</link>, <link linkend="ch0040s0018s0007li0026">26</link>). <emphasis>Aerococcus christensenii</emphasis>, isolated from the human genitourinary tract, was described by Collins and coworkers in 1999 (<link linkend="ch0040s0018s0007li0027">27</link>) and was joined by the species <emphasis>Aerococcus sanguinicola</emphasis> (originally named <emphasis>Aerococcus sanguicola</emphasis> [28, 29]) and <emphasis>Aerococcus urinaehominis</emphasis> (<link linkend="ch0040s0018s0007li0030">30</link>) in 2001. Complete whole-genome sequences of these five <emphasis>Aerococcus</emphasis> type strains have been obtained (<link linkend="ch0040s0018s0007li0031">31</link>).</para>
        <para id="ch0040s0001s0001p0007"><emphasis>Globicatella, Facklamia, Ignavigranum</emphasis>, and <emphasis>Dolosicoccus</emphasis> are related genera that are isolated infrequently from clinical specimens. <emphasis>Globicatella sanguinis</emphasis>, initially named <emphasis>Globicatella sanguis</emphasis>, was described in 1992 (<link linkend="ch0040s0018s0007li0032">32</link>). <emphasis>Facklamia</emphasis> currently contains four species isolated from human sources: <emphasis>Facklamia hominis</emphasis> (<link linkend="ch0040s0018s0007li0033">33</link>), <emphasis>Facklamia sourekii</emphasis> (<link linkend="ch0040s0018s0007li0034">34</link>), <emphasis>Facklamia ignava</emphasis> (<link linkend="ch0040s0018s0007li0035">35</link>), and <emphasis>Facklamia languida</emphasis> (<link linkend="ch0040s0018s0007li0036">36</link>). The genus <emphasis>Ignavigranum</emphasis>, currently consisting of a single species, <emphasis>Ignavigranum ruoffiae</emphasis>, was described by Collins and coworkers (<link linkend="ch0040s0018s0007li0037">37</link>), along with the genus <emphasis>Dolosicoccus</emphasis> and its single species, <emphasis>Dolosicoccus paucivorans</emphasis> (<link linkend="ch0040s0018s0007li0038">38</link>).</para>
        <para id="ch0040s0001s0001p0008">The genus<emphasis>Helcococcus</emphasis>, originally composed of the single species <emphasis>Helcococcus kunzii</emphasis> (<link linkend="ch0040s0018s0007li0039">39</link>), came to include a new species isolated from humans, <emphasis>Helcococcus sueciensis</emphasis>, in 2004 (<link linkend="ch0040s0018s0007li0040">40</link>). <emphasis>Helcococcus ovis</emphasis>, isolated from infections in animals, displays satelliting growth, unlike the human <emphasis>Helcococcus</emphasis> species (<link linkend="ch0040s0018s0007li0041">41</link>).</para>
      </sect2>
      <sect2 id="ch0040s0001s0002">
        <title>DESCRIPTION OF THE GENERA</title>
        <anchor id="ch0040s0001s0002a0001"/>
        <anchor id="ch0040s0001s0002a0002"/>
        <para id="ch0040s0001s0002p0001">The organisms included in this chapter form Gram-positive coccoid cells, but<emphasis>G. haemolysans</emphasis> may appear Gram variable or Gram negative due to the ease with which its cells are decolorized. Cell shape and arrangement can be used to divide these organisms into two broad groups: those with a “streptococcal” Gram stain (coccobacilli in pairs and chains) and those with a “staphylococcal” Gram stain (more spherical cocci in pairs, tetrads, clusters, or irregular groups). Dividing these diverse bacteria into two groups based on cellular shape and arrangement serves only as an aid in identification; no relatedness of organisms is implied by this grouping. <emphasis>Abiotrophia</emphasis> and <emphasis>Granulicatella</emphasis> isolates (formerly the nutritionally variant streptococci) form coccobacilli arranged in pairs and chains, but these organisms may also appear pleomorphic, especially when grown under suboptimal nutritional conditions (<link linkend="ch0040s0018s0007li0042">42</link>). With the exception of the infrequently isolated vagococci, these bacteria are all nonmotile. Most of the genera described here are catalase-negative facultative anaerobes, but <emphasis>A. viridans</emphasis> is classified as a microaerophile that grows poorly, if at all, under anaerobic conditions. Some strains of <emphasis>Aerococcus</emphasis> may exhibit weakly positive catalase reactions due to nonheme catalase activity. None of the genera is beta-hemolytic on routinely employed blood agars, but strains of <emphasis>G. haemolysans, G. bergeri</emphasis>, and <emphasis>G. sanguinis</emphasis> have been described as beta-hemolytic on agars supplemented with horse blood (<link linkend="ch0040s0018s0007li0019">19</link>, <link linkend="ch0040s0018s0007li0020">20</link>, <link linkend="ch0040s0018s0007li0043">43</link>).</para>
        <anchor id="ch0040s0001s0002a0003"/>
        <beginpage pagenum="472"/>
      </sect2>
      <sect2 id="ch0040s0001s0003">
        <title>EPIDEMIOLOGY AND TRANSMISSION</title>
        <anchor id="ch0040s0001s0003a0001"/>
        <anchor id="ch0040s0001s0003a0002"/>
        <para id="ch0040s0001s0003p0001">The organisms discussed in this chapter are opportunistic pathogens. Some of the genera have been characterized as constituents of the normal microbiota of the human oral cavity or upper respiratory tract (<emphasis>Gemella, Abiotrophia</emphasis>, and <emphasis>Granulicatella</emphasis>) and skin (<emphasis>Helcococcus</emphasis>). Lactococci, vagococci, pediococci, and leuconostocs can be isolated from foods and vegetation and may also be found as part of the normal microbiota of the alimentary tract (<link linkend="ch0040s0018s0007li0007">7</link>). Aerococci are environmental isolates that can also be found on human skin. Although they have been isolated from human clinical cultures, the natural habitats of many of the organisms mentioned here are not well characterized. The bacteria examined here seem to be of low virulence and are usually pathogenic in immunocompromised hosts. Infection often occurs in previously damaged tissues (e.g., heart valves) or may be nosocomial and associated with prolonged hospitalization, antibiotic treatment, invasive procedures, and the presence of foreign bodies.</para>
      </sect2>
      <sect2 id="ch0040s0001s0004">
        <title>CLINICAL SIGNIFICANCE</title>
        <anchor id="ch0040s0001s0004a0001"/>
        <anchor id="ch0040s0001s0004a0002"/>
        <para id="ch0040s0001s0004p0001">The bacteria described in this chapter may be present as contaminants in clinical cultures, but they are also isolated infrequently as opportunistic pathogens. Blood, cerebrospinal fluid, urine, and wound specimens are likely to yield significant isolates of these bacteria. Details on reported infections due to each of the genera follow.</para>
      </sect2>
    </sect1>
    <sect1 id="ch0040s0002">
      <title>Abiotrophia and Granulicatella</title>
      <anchor id="ch0040s0002a0001"/>
      <anchor id="ch0040s0002a0002"/>
      <para id="ch0040s0002p0001">Organisms in the genera<emphasis>Abiotrophia</emphasis> and <emphasis>Granulicatella</emphasis> are normal residents of the oral cavity and are recognized as agents of endocarditis involving both native and prosthetic valves (<link linkend="ch0040s0018s0007li0044">44</link>, <link linkend="ch0040s0018s0007li0045">45</link>). These organisms have also been isolated from other types of infections, including ophthalmic infections (<link linkend="ch0040s0018s0007li0046">46</link>), central nervous system infections (<link linkend="ch0040s0018s0007li0047">47</link>), peritonitis in patients undergoing continuous ambulatory peritoneal dialysis (<link linkend="ch0040s0018s0007li0048">48</link>), musculoskeletal infection (<link linkend="ch0040s0018s0007li0049">49</link>), septic arthritis (<link linkend="ch0040s0018s0007li0050">50</link>), and a breast implant-associated infection (<link linkend="ch0040s0018s0007li0051">51</link>).</para>
    </sect1>
    <sect1 id="ch0040s0003">
      <title>Aerococcus</title>
      <anchor id="ch0040s0003a0001"/>
      <anchor id="ch0040s0003a0002"/>
      <para id="ch0040s0003p0001"><emphasis>A. viridans</emphasis> has been noted as a contaminant in clinical cultures and infrequently as a clinically significant isolate from cases of endocarditis and bacteremia and a case of spondylodiscitis (<link linkend="ch0040s0018s0007li0052">52</link>, <link linkend="ch0040s0018s0007li0053">53</link>). Four additional <emphasis>Aerococcus</emphasis> species isolated from humans have been described since the early 1990s. <emphasis>A. urinae</emphasis> (<link linkend="ch0040s0018s0007li0054">54</link>) has been implicated as a urinary tract pathogen in patients predisposed to infection (approximately half of the patients have predisposing factors, either systemic [particularly diabetes mellitus and cancer] or local [indwelling catheter and/or hyperplasia of the prostate]) and as an agent of endocarditis (<link linkend="ch0040s0018s0007li0055">55</link>), lymphadenitis (<link linkend="ch0040s0018s0007li0056">56</link>), and peritonitis (<link linkend="ch0040s0018s0007li0057">57</link>). <emphasis>A. sanguinicola</emphasis> has been isolated from blood and urine specimens (<link linkend="ch0040s0018s0007li0028">28</link>, <link linkend="ch0040s0018s0007li0029">29</link>) and cases of urosepsis and endocarditis (<link linkend="ch0040s0018s0007li0055">55</link>). Eight clinical <emphasis>A. sanguinicola</emphasis> strains and 40 clinical <emphasis>A. urinae</emphasis> strains from episodes of urinary tract infections, bacteremia, and infective endocarditis have been whole-genome sequenced and analyzed for genomic diversity and characterization of virulence genes involved in bacterial pathogenicity (<link linkend="ch0040s0018s0007li0058">58</link>). Virulence genes associated with bacterial adhesion (<emphasis>A. sanguinicola</emphasis>: <emphasis>htpB, fbpA, lmb</emphasis>, and <emphasis>ilpA</emphasis>; <emphasis>A. urinae</emphasis>: <emphasis>htpB, lap, lmb, fbp-54</emphasis>, and <emphasis>ilpA</emphasis>) and antiphagocytosis (capsular polysaccharide gene homologs) were identified. Little is currently known about the clinical significance of <emphasis>A. christensenii</emphasis> (isolated from vaginal specimens [27] and <emphasis>A. urinaehominis</emphasis> (isolated from urine [30]).</para>
    </sect1>
    <sect1 id="ch0040s0004">
      <title>Dolosicoccus</title>
      <anchor id="ch0040s0004a0001"/>
      <anchor id="ch0040s0004a0002"/>
      <para id="ch0040s0004p0001">The single species of the genus<emphasis>Dolosicoccus, D. paucivorans</emphasis>, has been described from three blood cultures; one strain from a patient with pneumonia and two strains from patients without clinical information (<link linkend="ch0040s0018s0007li0038">38</link>, <link linkend="ch0040s0018s0007li0059">59</link>).</para>
    </sect1>
    <sect1 id="ch0040s0005">
      <title>Dolosigranulum</title>
      <anchor id="ch0040s0005a0001"/>
      <anchor id="ch0040s0005a0002"/>
      <para id="ch0040s0005p0001"><emphasis>Dolosigranulum</emphasis> is phenotypically similar, but not closely related, to <emphasis>Gemella</emphasis> (<link linkend="ch0040s0018s0007li0023">23</link>). The single species of the genus, <emphasis>Dolosigranulum pigrum</emphasis>, has been associated with nosocomial pneumonia and septicemia, synovitis (<link linkend="ch0040s0018s0007li0060">60</link>), acute cholecystitis accompanied by acute pancreatitis (<link linkend="ch0040s0018s0007li0061">61</link>), and biomaterial-associated arthritis (<link linkend="ch0040s0018s0007li0062">62</link>).</para>
    </sect1>
    <sect1 id="ch0040s0006">
      <title>Facklamia</title>
      <anchor id="ch0040s0006a0001"/>
      <anchor id="ch0040s0006a0002"/>
      <para id="ch0040s0006p0001">The genus<emphasis>Facklamia</emphasis> is closely related to, but phenotypically and phylogenetically distinct from, <emphasis>Globicatella</emphasis> (<link linkend="ch0040s0018s0007li0033">33</link>). Strains of the four <emphasis>Facklamia</emphasis> species isolated from humans have been recovered from blood, wound, and genitourinary sites (<link linkend="ch0040s0018s0007li0033">33</link>–<link linkend="ch0040s0018s0007li0036">36</link>). <emphasis>F. hominis</emphasis> has been reported to cause a case of chorioamnionitis (<link linkend="ch0040s0018s0007li0063">63</link>) and a case of infective endocarditis (<link linkend="ch0040s0018s0007li0064">64</link>).</para>
    </sect1>
    <sect1 id="ch0040s0007">
      <title>Gemella</title>
      <anchor id="ch0040s0007a0001"/>
      <anchor id="ch0040s0007a0002"/>
      <para id="ch0040s0007p0001">The two most pathogenic species in the genus<emphasis>Gemella</emphasis> are <emphasis>G. morbillorum</emphasis> and <emphasis>G. haemolysans,</emphasis> and the predominant clinical diseases caused by these two species are bacteremia<emphasis>/</emphasis>sepsis, infective endocarditis (<link linkend="ch0040s0018s0007li0065">65</link>–<link linkend="ch0040s0018s0007li0067">67</link>), brain abscess (<link linkend="ch0040s0018s0007li0068">68</link>, <link linkend="ch0040s0018s0007li0069">69</link>), and bone and joint infections (<link linkend="ch0040s0018s0007li0070">70</link>, <link linkend="ch0040s0018s0007li0071">71</link>). In addition, <emphasis>G. haemolysans</emphasis> has been isolated from meningitis (<link linkend="ch0040s0018s0007li0072">72</link>) and ocular infections (<link linkend="ch0040s0018s0007li0073">73</link>, <link linkend="ch0040s0018s0007li0074">74</link>), whereas <emphasis>G. morbillorum</emphasis> has been implicated in cases of liver abscesses, pleural empyemas and lung abscess (<link linkend="ch0040s0018s0007li0075">75</link>), and peritonitis (<link linkend="ch0040s0018s0007li0076">76</link>). Information on the clinical significance of the other <emphasis>Gemella</emphasis> species continues to accumulate. <emphasis>G. bergeri</emphasis> and <emphasis>G. sanguinis</emphasis> have been isolated from blood cultures, and they may also be causative agents of endocarditis (<link linkend="ch0040s0018s0007li0019">19</link>, <link linkend="ch0040s0018s0007li0020">20</link>, <link linkend="ch0040s0018s0007li0077">77</link>). A strain of <emphasis>G. sanguinis</emphasis> was isolated from an infected prosthetic hip joint (<link linkend="ch0040s0018s0007li0078">78</link>), and <emphasis>G. asaccharolytica</emphasis> has been isolated from wound cultures (<link linkend="ch0040s0018s0007li0021">21</link>). <emphasis>G. parahaemolysans</emphasis> and <emphasis>G. taiwanensis</emphasis> have been isolated from blood cultures (<link linkend="ch0040s0018s0007li0022">22</link>).</para>
      <para id="ch0040s0007p0002">Based on the genomic and proteomic information available from NCBI, Garcia López and Martin-Galiano (<link linkend="ch0040s0018s0007li0079">79</link>) found that a number of well-known virulence factors were harbored by all <emphasis>Gemella</emphasis> species, such as a manganese transport/adhesin sharing 83% identity with a protein from oral endocarditis-causing streptococci.</para>
    </sect1>
    <sect1 id="ch0040s0008">
      <title>Globicatella</title>
      <anchor id="ch0040s0008a0001"/>
      <anchor id="ch0040s0008a0002"/>
      <para id="ch0040s0008p0001"><emphasis>G. sanguinis</emphasis>, isolated from human clinical specimens, has been implicated in cases of bacteremia, urinary tract infection, osteomyelitis, and meningitis (<link linkend="ch0040s0018s0007li0032">32</link>, <link linkend="ch0040s0018s0007li0080">80</link>, <link linkend="ch0040s0018s0007li0081">81</link>).</para>
    </sect1>
    <sect1 id="ch0040s0009">
      <title>Helcococcus</title>
      <anchor id="ch0040s0009a0001"/>
      <anchor id="ch0040s0009a0002"/>
      <para id="ch0040s0009p0001"><emphasis>H. kunzii</emphasis> can be isolated from intact skin of the lower extremities as well as from mixed cultures of wounds, notably foot infections (<link linkend="ch0040s0018s0007li0039">39</link>). In such scenarios, the clinical significance of this organism is difficult to interpret, since it may be present merely as a colonizer of the wound site. The ability of <emphasis>H. kunzii</emphasis> to function as an opportunist is, however, suggested by its isolation as the sole or predominant organism from cases of skin and soft tissue abscesses, bacteremia, pleural empyema, prosthetic joint infection, and brain abscess (<link linkend="ch0040s0018s0007li0082">82</link>). One additional species isolated from humans, <emphasis>H. sueciensis,</emphasis> is based on a single isolate from wound infection (<link linkend="ch0040s0018s0007li0040">40</link>).</para>
      <anchor id="ch0040s0009a0003"/>
      <beginpage pagenum="473"/>
    </sect1>
    <sect1 id="ch0040s0010">
      <title>Ignavigranum</title>
      <anchor id="ch0040s0010a0001"/>
      <anchor id="ch0040s0010a0002"/>
      <para id="ch0040s0010p0001">A limited number of isolates of<emphasis>I. ruoffiae</emphasis>, the sole species of <emphasis>Ignavigranum</emphasis>, have been described to date. Sites of isolation include a wound and an ear abscess (<link linkend="ch0040s0018s0007li0037">37</link>).</para>
    </sect1>
    <sect1 id="ch0040s0011">
      <title>Lactococcus</title>
      <anchor id="ch0040s0011a0001"/>
      <anchor id="ch0040s0011a0002"/>
      <para id="ch0040s0011p0001">Due to their phenotypic similarities with streptococci and enterococci, clinical isolates of lactococci have probably been misidentified in the past, accounting at least in part for the paucity of reports concerning the clinical role of these bacteria. Elliott and coworkers (<link linkend="ch0040s0018s0007li0083">83</link>) studied the phenotypic characteristics of a number of lactococcal strains isolated from blood, urinary tract infections, and an eye wound culture. Lactococci have been associated with native-valve and prosthetic-valve endocarditis, septicemia in an immunosuppressed patient, osteomyelitis, spondylodiscitis (<link linkend="ch0040s0018s0007li0084">84</link>), peritonitis (<link linkend="ch0040s0018s0007li0085">85</link>), liver abscess (<link linkend="ch0040s0018s0007li0086">86</link>), acalculous cholecystitis (<link linkend="ch0040s0018s0007li0087">87</link>), and prosthetic joint infection (<link linkend="ch0040s0018s0007li0088">88</link>). <emphasis>L. garvieae</emphasis> is a known pathogen of aquacultured fish, and human infections have been linked to consumption of or contact with fish (<link linkend="ch0040s0018s0007li0084">84</link>, <link linkend="ch0040s0018s0007li0088">88</link>).</para>
    </sect1>
    <sect1 id="ch0040s0012">
      <title>Leuconostoc</title>
      <anchor id="ch0040s0012a0001"/>
      <anchor id="ch0040s0012a0002"/>
      <para id="ch0040s0012p0001"><emphasis>Leuconostoc, Pediococcus</emphasis>, and <emphasis>Weissella</emphasis> are three genera of catalase-negative Gram-positive coccoid bacteria that are innately resistant to vancomycin. The genera <emphasis>Leuconostoc</emphasis> and <emphasis>Pediococcus</emphasis> were first recognized in clinical specimens in the mid-1980s. Handwerger and colleagues (<link linkend="ch0040s0018s0007li0089">89</link>) observed that host defense impairment, invasive procedures breaching the integument, gastrointestinal symptoms, and prior antibiotic treatment were common features among adult patients with <emphasis>Leuconostoc</emphasis> infection. They also noted a predisposition to <emphasis>Leuconostoc</emphasis> bacteremia among neonates, suggesting that infants may become colonized during delivery by <emphasis>Leuconostoc</emphasis> spp. inhabiting the maternal genital tract. <emphasis>Leuconostoc</emphasis> spp. have been isolated from blood, cerebrospinal fluid, peritoneal dialysate fluid, and wounds. Case reports have implicated <emphasis>Leuconostoc</emphasis> spp. as agents of infection in osteomyelitis (<link linkend="ch0040s0018s0007li0090">90</link>), ventriculitis (<link linkend="ch0040s0018s0007li0091">91</link>), brain abscess (<link linkend="ch0040s0018s0007li0092">92</link>), postsurgical endophthalmitis (<link linkend="ch0040s0018s0007li0093">93</link>), and bacteremia in the setting of short gut syndrome. Short gut syndrome favors a microbiota with a high prevalence of <emphasis>Lactobacillus</emphasis> and <emphasis>Leuconostoc</emphasis> bacteria (<link linkend="ch0040s0018s0007li0094">94</link>). Several reports have related <emphasis>Leuconostoc</emphasis> bacteremic episodes to the presence of short gut syndrome, central venous catheters, and disrupted bowel mucosa (<link linkend="ch0040s0018s0007li0095">95</link>).</para>
    </sect1>
    <sect1 id="ch0040s0013">
      <title>Pediococcus</title>
      <anchor id="ch0040s0013a0001"/>
      <anchor id="ch0040s0013a0002"/>
      <para id="ch0040s0013p0001"><emphasis>Pediococcus</emphasis> strains have been isolated from bacteremia and cases of sepsis and hepatic abscess in compromised patients (<link linkend="ch0040s0018s0007li0096">96</link>, <link linkend="ch0040s0018s0007li0097">97</link>). Barros and coworkers (<link linkend="ch0040s0018s0007li0014">14</link>) noted that <emphasis>P. acidilactici</emphasis> was isolated from clinical specimens more frequently than <emphasis>P. pentosaceus</emphasis> and was also more commonly isolated from cases of bacteremia. Barton and coworkers noted the role of <emphasis>Pediococcus</emphasis> in bacteremia in infants with gastrointestinal malformations requiring surgical correction (<link linkend="ch0040s0018s0007li0098">98</link>).</para>
    </sect1>
    <sect1 id="ch0040s0014">
      <title>Vagococcus</title>
      <anchor id="ch0040s0014a0001"/>
      <anchor id="ch0040s0014a0002"/>
      <para id="ch0040s0014p0001">Vagococci are motile organisms that, like lactococci, express Lancefield group N antigen (<link linkend="ch0040s0018s0007li0007">7</link>). Difficulties encountered in identifying vagococci may partially account for their infrequent recognition in clinical cultures. To date, only a few <emphasis>Vagococcus</emphasis> isolates from human sources have been reported. Teixeira and coworkers (<link linkend="ch0040s0018s0007li0099">99</link>) described strains isolated from blood, peritoneal fluid, and a wound. Al-Ahmad and colleagues reported isolation of <emphasis>V. fluvialis</emphasis> from an infected root canal system (<link linkend="ch0040s0018s0007li0100">100</link>). <emphasis>Vagococcus lutrae</emphasis> has been isolated from blood culture (<link linkend="ch0040s0018s0007li0101">101</link>) and skin lesions (<link linkend="ch0040s0018s0007li0102">102</link>). A newly recognized species, <emphasis>Vagococcus vulneris</emphasis>, was isolated from a human foot wound (<link linkend="ch0040s0018s0007li0006">6</link>).</para>
    </sect1>
    <sect1 id="ch0040s0015">
      <title>Weissella</title>
      <anchor id="ch0040s0015a0001"/>
      <anchor id="ch0040s0015a0002"/>
      <para id="ch0040s0015p0001"><emphasis>Weissella</emphasis> strains are usually isolated in polymicrobial infections. They are often confused with <emphasis>Lactobacillus</emphasis> or viridans streptococci and may be considered contaminants (<link linkend="ch0040s0018s0007li0103">103</link>). <emphasis>Weissella confusa</emphasis>, formerly classified as <emphasis>Lactobacillus confusus</emphasis>, has been reported infrequently as an agent of bacteremia, endocarditis, prosthetic joint infections, abscesses (<link linkend="ch0040s0018s0007li0103">103</link>), and meningitis (<link linkend="ch0040s0018s0007li0104">104</link>). <emphasis>Weissella cibaria</emphasis> isolates have been identified in the urine, lung, and blood of patients with bacteremia. <emphasis>W. viridescens</emphasis> has been recovered from human blood. The clinical significance of infections with these species is not yet clear (<link linkend="ch0040s0018s0007li0013">13</link>, <link linkend="ch0040s0018s0007li0103">103</link>).</para>
      <sect2 id="ch0040s0015s0001">
        <title>COLLECTION, TRANSPORT, AND STORAGE OF SPECIMENS</title>
        <anchor id="ch0040s0015s0001a0001"/>
        <anchor id="ch0040s0015s0001a0002"/>
        <para id="ch0040s0015s0001p0001">No special requirements for collection and transport of specimens for isolation of the organisms discussed in this chapter have been described. Routine procedures for collection, transport, and storage of specimens for aerobic culture allow the isolation of these bacteria, since the majority are facultative anaerobes or microaerophiles. These organisms may also be recovered from specimens that have been collected and transported under anaerobic conditions (see<ulink url="ch0035#ch0035s0001">chapter 19</ulink>).</para>
      </sect2>
      <sect2 id="ch0040s0015s0002">
        <title>DIRECT EXAMINATION</title>
        <anchor id="ch0040s0015s0002a0001"/>
        <anchor id="ch0040s0015s0002a0002"/>
        <para id="ch0040s0015s0002p0001">The organisms described in this chapter can be visualized in direct Gram stains of clinical material but have no outstanding morphological characteristics that distinguish them from commonly isolated Gram-positive cocci (streptococci and staphylococci). Although<emphasis>Abiotrophia</emphasis> and <emphasis>Granulicatella</emphasis> isolates may appear pleomorphic in direct Gram stains, they form Gram-positive cocci in pairs and chains when grown on nutritionally adequate media. Direct detection of these genera by antigenic methods has not been described. Amplification and sequencing of 16S rRNA genes and matrix-assisted laser desorption ionization–time-of-flight mass spectrometry (MALDI-TOF MS) have been evaluated for direct or rapid detection of these organisms in clinical specimens (<link linkend="ch0040s0018s0007li0105">105</link>–<link linkend="ch0040s0018s0007li0107">107</link>).</para>
      </sect2>
      <sect2 id="ch0040s0015s0003">
        <title>ISOLATION PROCEDURES</title>
        <anchor id="ch0040s0015s0003a0001"/>
        <anchor id="ch0040s0015s0003a0002"/>
        <para id="ch0040s0015s0003p0001">Generally, there are no special requirements for isolation of the group of bacteria discussed here; general recommendations for the culture of blood, body fluids, and other specimens should be followed (see<ulink url="ch0035#ch0035s0001">chapter 19</ulink>). These organisms are likely to be isolated on rich, nonselective media (e.g., blood or chocolate agar and thioglycolate broth), since they are nutritionally fastidious. If selective isolation of the vancomycin-resistant genera <emphasis>Leuconostoc</emphasis> and <emphasis>Pediococcus</emphasis> is desired, Thayer-Martin medium may be used to inhibit the normal microbiota or other contaminating microorganisms (<link linkend="ch0040s0018s0007li0108">108</link>). Some of the genera (e.g., <emphasis>Helcococcus</emphasis>) grow slowly, forming tiny colonies that may not be visible unless extended incubation (48 to 72 h) is employed. The recovery of many of the genera included in this chapter may be enhanced by CO<subscript>2</subscript> enrichment of the incubation atmosphere. Members of the genera <emphasis>Abiotrophia</emphasis> and <emphasis>Granulicatella</emphasis> usually grow on chocolate agar, on brucella agar with 5% horse blood, and in thioglycolate broth but not on Trypticase soy agar with 5% sheep blood. These organisms can be cultured on nonsupportive media that have been appropriately supplemented (see “<emphasis>Abiotrophia</emphasis> and <emphasis>Granulicatella</emphasis>” in “Procedures for Phenotypic Differentiation” below).</para>
        <anchor id="ch0040s0015s0003a0003"/>
        <beginpage pagenum="474"/>
      </sect2>
      <sect2 id="ch0040s0015s0004">
        <title>IDENTIFICATION</title>
        <anchor id="ch0040s0015s0004a0001"/>
        <anchor id="ch0040s0015s0004a0002"/>
      </sect2>
    </sect1>
    <sect1 id="ch0040s0016">
      <title>Procedures for Phenotypic Differentiation</title>
      <anchor id="ch0040s0016a0001"/>
      <anchor id="ch0040s0016a0002"/>
      <para id="ch0040s0016p0001">While molecular characterization may be required for accurate species-level identification of the aerobic catalase-negative, Gram-positive cocci encountered infrequently in clinical laboratories, phenotypic methods can be helpful in characterization of these bacteria to the genus level. Gram stain morphology has been employed as a major decision point in the identification protocols in<anchor id="ch0040s0016a0003"/><link linkend="ch0040s0016a0008">Fig. 1</link> and <anchor id="ch0040s0016a0004"/><link linkend="ch0040s0016a0010">2</link> and <link linkend="ch0040s0001s0001a0005">Table 1</link>, with two general categories: morphology resembling that of streptococci, meaning cocci or coccobacilli in pairs and chains, and staphylococcal morphology, consisting of coccoid cells arranged in pairs, clusters, tetrads, or irregular groups. <anchor id="ch0040s0016a0005"/><link linkend="ch0040s0016s0008a0005">Figure 3</link> shows microscopic morphology of type strains from 11 species. Broth-grown cells (thioglycolate broth is suitable) should be used for making accurate morphological determinations. Note that <emphasis>Gemella</emphasis> and <emphasis>Facklamia</emphasis> strains may display either type of cellular morphology, depending on the species. <link linkend="ch0040s0016a0008">Figures 1</link> and <link linkend="ch0040s0016a0010">2</link> display phenotypic tests used to differentiate the genera of bacteria discussed in this chapter. Descriptions of tests for catalase, PYR, LAP, β-glucuronidase, and hippurate hydrolysis, as well as bile esculin agar and <emphasis>Lactobacillus</emphasis> MRS (DeMan, Rogosa, Sharpe) broth medium, can be found in reference <link linkend="ch0040s0018s0007li0007">7</link>. Additional phenotypic tests are described below in the discussion of identification criteria for each genus.</para>
      <anchor id="ch0040s0016a0006"/>
      <beginpage pagenum="475"/>
      <figure id="ch0040s0016f0001"><title><anchor id="ch0040s0016a0007"/><emphasis role="strong"><phrase role="figureLabel"><anchor id="ch0040s0016a0008"/><link linkend="ch0040s0016a0003">FIGURE 1</link></phrase></emphasis> Identification of catalase-negative, Gram-positive cocci that grow aerobically with cells arranged in pairs and chains. PYR, pyrrolidonyl arylamidase activity; LAP, leucine aminopeptidase activity; 6.5% NaCl, growth in broth containing 6.5% NaCl; bile esculin, hydrolysis of esculin in the presence of 40% bile; Motility, motile in motility test medium; 45°C, growth at 45°C; 10°C, growth at 10°C; Probe, reaction with commercially available nucleic acid probe for the genus <emphasis>Enterococcus</emphasis>; HIP, hydrolysis of hippurate; Satellitism, satelliting growth behavior; ARG, arginine hydrolysis activity; BGUR, β-glucuronidase activity.
</title>
        
        <mediaobject>
          <imageobject>
            <imagedata fileref="Ch0040f04.jpg" width="100%" scalefit="1"/>
          </imageobject>
        </mediaobject>
      </figure>
      <figure id="ch0040s0016f0002"><title><anchor id="ch0040s0016a0009"/><emphasis role="strong"><phrase role="figureLabel"><anchor id="ch0040s0016a0010"/><link linkend="ch0040s0016a0004">FIGURE 2</link></phrase></emphasis> Identification of catalase-negative, Gram-positive cocci that grow aerobically with cells arranged in pairs, tetrads, and clusters or irregular groups. PYR, pyrrolidonyl arylamidase activity; LAP, leucine aminopeptidase activity; 6.5% NaCl, growth in broth containing 6.5% NaCl; Esculin, hydrolysis of esculin; BGUR, β-glucuronidase activity. <superscript><emphasis>a,</emphasis></superscript> Two additional <emphasis>Gemella</emphasis> species, <emphasis>Gemella parahaemolysans</emphasis> and <emphasis>Gemella taiwanensis</emphasis>, are described as resembling <emphasis>G. haemolysans</emphasis>. See reference <link linkend="ch0040s0018s0007li0022">22</link> for details.
</title>
        
        <mediaobject>
          <imageobject>
            <imagedata fileref="Ch0040f02.jpg" width="100%" scalefit="1"/>
          </imageobject>
        </mediaobject>
      </figure>
      <sect2 id="ch0040s0016s0001">
        <title>Abiotrophia and Granulicatella</title>
        <anchor id="ch0040s0016s0001a0001"/>
        <anchor id="ch0040s0016s0001a0002"/>
        <para id="ch0040s0016s0001p0001">A test for satelliting behavior is important for identification of<emphasis>Abiotrophia</emphasis> and <emphasis>Granulicatella</emphasis>. The strain to be examined is streaked for confluent growth on a medium that does not support growth or supports only weak growth (e.g., sheep blood agar). A single cross streak of <emphasis>Staphylococcus aureus</emphasis> (ATCC 25923 or another suitable strain) is applied to the inoculated area. After incubation at 35°C in an atmosphere containing elevated CO<subscript>2</subscript>, strains of <emphasis>Abiotrophia</emphasis> or <emphasis>Granulicatella</emphasis> grow only in the vicinity of the staphylococcal growth. Some strains of <emphasis>Ignavigranum</emphasis> may also show satelliting behavior (<link linkend="ch0040s0018s0007li0037">37</link>). Alternatively, media can be supplemented with pyridoxal. An aqueous stock solution of filter-sterilized 0.01% pyridoxal hydrochloride (which can be stored frozen) should be added to media to achieve a final concentration of 0.001%. Pyridoxal disks (Remel, Thermo Fisher Scientific, Waltham, MA) may also be used in the satelliting test. Detailed phenotypic information for the PYR- and LAP-positive <emphasis>Abiotrophia</emphasis> and <emphasis>Granulicatella</emphasis> species can be found in references <link linkend="ch0040s0018s0007li0008">8</link>, <link linkend="ch0040s0018s0007li0042">42</link>, <link linkend="ch0040s0018s0007li0109">109</link>, and <link linkend="ch0040s0018s0007li0110">110</link>.</para>
      </sect2>
      <sect2 id="ch0040s0016s0002">
        <title>Aerococcus</title>
        <anchor id="ch0040s0016s0002a0001"/>
        <anchor id="ch0040s0016s0002a0002"/>
        <para id="ch0040s0016s0002p0001">The PYR-positive, LAP-negative member of the genus<emphasis>Aerococcus, A. viridans</emphasis>, is characterized by displaying weak or no growth when incubated in an anaerobic atmosphere (<link linkend="ch0040s0018s0007li0111">111</link>). This trait can be tested by incubating duplicate blood agar plate cultures of the organism in question in anaerobic and aerobic atmospheres and comparing growth after 24 to 48 h. <emphasis>A. viridans</emphasis> forms alpha-hemolytic colonies that could be confused with those of either viridans group streptococci or enterococci. <emphasis>A. sanguinicola</emphasis> is positive in the PYR and LAP tests, while <emphasis>A. urinaehominis</emphasis> is negative in both. The PYR-negative, LAP-positive species, <emphasis>A. urinae</emphasis> and <emphasis>A. christensenii</emphasis>, are differentiated by production of β-glucuronidase (<emphasis>A. christensenii</emphasis> is negative and <emphasis>A. urinae</emphasis> is positive). <emphasis>A. urinae</emphasis> forms small (0.5 mm in diameter after 24 h of incubation), alpha-hemolytic, convex, shiny, transparent colonies on blood agar media. Additional information on the identifying characteristics of <emphasis>A. urinae</emphasis> can be found in reference <link linkend="ch0040s0018s0007li0112">112</link>, and a second biotype (esculin hydrolysis positive) of this species is described in reference <link linkend="ch0040s0018s0007li0026">26</link>. Additional information on phenotypic traits of the species <emphasis>A. christensenii, A. sanguinicola</emphasis>, and <emphasis>A. urinaehominis</emphasis> can be found in <link linkend="ch0040s0001s0001a0005">Table 1</link>, <link linkend="ch0040s0016a0010">Fig. 2</link>, and references <link linkend="ch0040s0018s0007li0027">27</link>–<link linkend="ch0040s0018s0007li0030">30</link>.</para>
        <anchor id="ch0040s0016s0002a0003"/>
        <beginpage pagenum="476"/>
      </sect2>
      <sect2 id="ch0040s0016s0003">
        <title>Dolosigranulum</title>
        <anchor id="ch0040s0016s0003a0001"/>
        <anchor id="ch0040s0016s0003a0002"/>
        <para id="ch0040s0016s0003p0001"><emphasis>D. pigrum</emphasis>, the sole species of <emphasis>Dolosigranulum</emphasis> described to date, displays positive PYR and LAP reactions and was initially described as phenotypically similar, though not closely related, to members of the genus <emphasis>Gemella</emphasis> (<link linkend="ch0040s0018s0007li0023">23</link>). <emphasis>D. pigrum</emphasis> is distinguished from <emphasis>Gemella</emphasis> spp. by its abilities to hydrolyze arginine and to grow in the presence of 6.5% NaCl.</para>
      </sect2>
      <sect2 id="ch0040s0016s0004">
        <title>Gemella</title>
        <anchor id="ch0040s0016s0004a0001"/>
        <anchor id="ch0040s0016s0004a0002"/>
        <para id="ch0040s0016s0004p0001">On sheep blood agar media, members of the genus<emphasis>Gemella</emphasis> (usually PYR positive) form small colonies that are similar in appearance to those of viridans-group streptococci. Slow growth of some <emphasis>Gemella</emphasis> strains may lead to confusion of these organisms with <emphasis>Abiotrophia</emphasis> or <emphasis>Granulicatella</emphasis>. A test for satelliting behavior should separate these two groups of bacteria (<link linkend="ch0040s0018s0007li0113">113</link>), but Leung and coworkers (<link linkend="ch0040s0018s0007li0078">78</link>) reported a single <emphasis>G. sanguinis</emphasis> strain that exhibited “pseudosatelliting” behavior (satelliting growth after 24 h but widespread growth after 48 h of incubation). Cells of <emphasis>G. haemolysans</emphasis> are easily decolorized and resemble those of neisseriae, since they occur in pairs with the adjacent sides flattened. <emphasis>G. haemolysans</emphasis> grows best in an aerobic atmosphere. The esculin hydrolysis test for differentiation of <emphasis>G. haemolysans</emphasis> and <emphasis>R. mucilaginosa</emphasis> listed in <link linkend="ch0040s0016a0010">Fig. 2</link> is performed with esculin agar slants (heart infusion agar containing 0.1% esculin and 0.5% ferric citrate) that are inoculated and incubated at 35°C for up to 7 days. Partial or complete blackening of the agar indicates a positive reaction (<link linkend="ch0040s0018s0007li0007">7</link>). <emphasis>G. morbillorum</emphasis> cells are Gram positive and arranged in pairs and short chains; individual cells in a given pair may be of unequal sizes. Only a small number of strains of <emphasis>G. bergeri</emphasis> and <emphasis>G. sanguinis</emphasis> have been reported to date. Information on phenotypic characteristics of these <emphasis>Gemella</emphasis> species can be found in references <link linkend="ch0040s0018s0007li0019">19</link> and <link linkend="ch0040s0018s0007li0020">20</link>. The recently described <emphasis>G. asaccharolytica</emphasis> is PYR negative, unlike other <emphasis>Gemella</emphasis> species (<link linkend="ch0040s0018s0007li0021">21</link>). Phenotypic characteristics of <emphasis>G. parahaemolysans</emphasis> and <emphasis>G. taiwanensis</emphasis> are summarized in reference <link linkend="ch0040s0018s0007li0022">22</link>.</para>
      </sect2>
      <sect2 id="ch0040s0016s0005">
        <title>Globicatella and Related Genera (Facklamia, Dolosicoccus, and Ignavigranum)</title>
        <anchor id="ch0040s0016s0005a0001"/>
        <anchor id="ch0040s0016s0005a0002"/>
        <para id="ch0040s0016s0005p0001"><emphasis>Globicatella</emphasis> and the related genera <emphasis>Facklamia, Dolosicoccus</emphasis>, and <emphasis>Ignavigranum</emphasis> are all, with the exception of the species <emphasis>Globicatella sulfidifaciens</emphasis>, PYR positive. <emphasis>Facklamia</emphasis> and <emphasis>Ignavigranum</emphasis> are also LAP positive and salt tolerant. <emphasis>Globicatella</emphasis> is LAP negative and salt tolerant, while <emphasis>Dolosicoccus</emphasis> is LAP negative and salt intolerant. <emphasis>Dolosicoccus</emphasis> strains are also hippurate hydrolysis negative, which further distinguishes them from strains of <emphasis>Facklamia</emphasis> and <emphasis>Globicatella</emphasis> (hippurate hydrolysis positive). Strains of <emphasis>F. hominis</emphasis> and <emphasis>Ignavigranum</emphasis> may produce urease. <emphasis>Ignavigranum</emphasis> strains may exhibit satelliting behavior. Further details of phenotypic traits of these organisms can be found in references <link linkend="ch0040s0018s0007li0033">33</link>–<link linkend="ch0040s0018s0007li0038">38</link>, and <link linkend="ch0040s0018s0007li0114">114</link>.</para>
      </sect2>
      <sect2 id="ch0040s0016s0006">
        <title>Helcococcus</title>
        <anchor id="ch0040s0016s0006a0001"/>
        <anchor id="ch0040s0016s0006a0002"/>
        <para id="ch0040s0016s0006p0001">Colonial morphology (tiny, gray, usually slightly alpha-hemolytic colonies), good growth under anaerobic conditions, and stimulation of growth by the addition of 1% horse serum or 0.1% Tween 80 to the medium differentiate<emphasis>H. kunzii</emphasis> from aerococci (<link linkend="ch0040s0018s0007li0039">39</link>). Isolates of <emphasis>H. kunzii</emphasis> are PYR positive. An additional <emphasis>Helcococcus</emphasis> species isolated from humans, <emphasis>H. sueciensis,</emphasis> is negative in the PYR test. Detailed phenotypic data on these organisms can be found in references <link linkend="ch0040s0018s0007li0039">39</link>, <link linkend="ch0040s0018s0007li0040">40</link>, and <link linkend="ch0040s0018s0007li0041">41</link>.</para>
      </sect2>
      <sect2 id="ch0040s0016s0007">
        <title>Lactococcus and Vagococcus</title>
        <anchor id="ch0040s0016s0007a0001"/>
        <anchor id="ch0040s0016s0007a0002"/>
        <para id="ch0040s0016s0007p0001">The members of the genera<emphasis>Lactococcus</emphasis> and <emphasis>Vagococcus</emphasis> are usually PYR and LAP positive, grow in the presence of 6.5% NaCl, and can be confused with enterococci or streptococci. For the salt tolerance test, heart infusion broth supplemented with 6.0% NaCl (producing a final NaCl concentration of 6.5%), with or without the acid-base indicator bromcresol purple, is inoculated with two or three colonies and incubated at 35°C for up to 72 h. Turbidity with or without a color change from purple to yellow indicates growth (<link linkend="ch0040s0018s0007li0007">7</link>, <link linkend="ch0040s0018s0007li0113">113</link>). Facklam and colleagues (<link linkend="ch0040s0018s0007li0007">7</link>, <link linkend="ch0040s0018s0007li0113">113</link>) recommended growth temperature tests for distinguishing lactococci from streptococci and enterococci. Consult <link linkend="ch0040s0016a0008">Fig. 1</link> for growth temperature characteristics of each of the genera. For growth temperature tests, broths (heart infusion broth containing 1% glucose and bromcresol purple indicator) are inoculated with a single colony or drop of broth culture of the test strain and incubated at 35°C for up to 7 days. A water bath is recommended for incubation of cultures at 45°C. Turbidity with or without a change in the broth’s indicator to yellow indicates a positive test. The motile vagococci can be distinguished from lactococci with modified motility test medium, stab inoculated, and incubated at 30°C for up to 48 h, according to the method of Facklam and Elliott (<link linkend="ch0040s0018s0007li0007">7</link>). Further information on the phenotypic traits of <emphasis>Lactococcus</emphasis> and <emphasis>Vagococcus</emphasis> isolates may be found in references <link linkend="ch0040s0018s0007li0003">3</link>, <link linkend="ch0040s0018s0007li0083">83</link>, <link linkend="ch0040s0018s0007li0099">99</link>, and <link linkend="ch0040s0018s0007li0115">115</link>.</para>
      </sect2>
      <sect2 id="ch0040s0016s0008">
        <title>Leuconostoc, Pediococcus, and Weissella</title>
        <anchor id="ch0040s0016s0008a0001"/>
        <anchor id="ch0040s0016s0008a0002"/>
        <para id="ch0040s0016s0008p0001">Members of the PYR-negative, vancomycin-resistant genera<emphasis>Leuconostoc, Pediococcus</emphasis>, and <emphasis>Weissella</emphasis> produce small, alpha-hemolytic or nonhemolytic colonies on blood agar. Vancomycin resistance can be tested for identification purposes by streaking several colonies over half of a plate containing Trypticase soy agar with 5% sheep blood. After a 30-μg vancomycin disk has been placed in the center of the inoculated area, the plate is incubated overnight in a CO<subscript>2</subscript>-enriched atmosphere at 35°C. Any zone of inhibition indicates susceptibility, while resistant strains exhibit no inhibition zone (<link linkend="ch0040s0018s0007li0007">7</link>, <link linkend="ch0040s0018s0007li0113">113</link>). In addition to having different cellular morphologies (<link linkend="ch0040s0001s0001a0005">Table 1</link>), these vancomycin-resistant genera, along with vancomycin-resistant strains of lactobacilli that form short coccoid cells, can be differentiated by tests for gas production from glucose and arginine hydrolysis. <emphasis>Leuconostoc</emphasis> spp. produce gas and are always arginine negative. Lactobacilli are variable in both tests, but a positive arginine test for a gas-producing strain would rule out identification of the organism as a leuconostoc. Pediococci are gas production negative and show variable reactions in the arginine test, although <emphasis>P. acidilactici</emphasis> and <emphasis>P. pentosaceus</emphasis>, the two species commonly found in clinical material, are arginine positive.</para>
        <para id="ch0040s0016s0008p0002"><emphasis>Weissella</emphasis> strains may be misidentified as <emphasis>Leuconostoc</emphasis> spp. or lactobacilli. These organisms produce gas from glucose. The few clinical isolates reported in the literature have been described as positive for hydrolysis of arginine (<link linkend="ch0040s0018s0007li0012">12</link>). MRS broth (BD Diagnostic Systems, Franklin Lakes, NJ; Hardy Diagnostics, Santa Maria, CA), sealed with melted petrolatum and incubated for up to 7 days at 35°C, is used to test for gas production, indicated by displacement of the petrolatum plug (<link linkend="ch0040s0018s0007li0007">7</link>, <link linkend="ch0040s0018s0007li0113">113</link>). The arginine hydrolysis test can be performed with Moeller decarboxylase broth containing arginine (<link linkend="ch0040s0018s0007li0007">7</link>). Lancefield group D antigen can be detected in pediococci (<link linkend="ch0040s0018s0007li0113">113</link>). References <link linkend="ch0040s0018s0007li0007">7</link>, <link linkend="ch0040s0018s0007li0011">11</link>, <link linkend="ch0040s0018s0007li0014">14</link>, and <link linkend="ch0040s0018s0007li0113">113</link> should be consulted for further information on identification of <emphasis>Leuconostoc</emphasis> and <emphasis>Pediococcus</emphasis> to the species level.</para>
        <anchor id="ch0040s0016s0008a0003"/>
        <beginpage pagenum="477"/>
        <figure id="ch0040s0016s0008f0001"><title><anchor id="ch0040s0016s0008a0004"/><emphasis role="strong"><phrase role="figureLabel"><anchor id="ch0040s0016s0008a0005"/><link linkend="ch0040s0016a0005">FIGURE 3</link></phrase></emphasis> Microscopic morphology of several aerobic catalase-negative, Gram-positive cocci type strains, Gram stained and viewed by bright-field microscopy. All strains except for that in panel A.b were cultured on 5% Danish horse blood agar in ambient atmosphere supplemented with 5% CO<subscript>2</subscript> at 37°C for 24 h. The strain in panel A.b was cultured in serum broth in ambient atmosphere at 37°C for 24 h. All photomicrographs were taken at ×1,000 magnification. (A.a) <emphasis>Abiotrophia defectiva</emphasis>, cocci in short chains with variable Gram staining when cultured on blood agar; (A.b) <emphasis>Abiotrophia defectiva</emphasis>, cocci with more even Gram staining and improved chain formation and cell morphology when cultured in serum broth; (B) <emphasis>Gemella haemolysans</emphasis>, cocci in pairs and short chains; (C) <emphasis>Facklamia hominis</emphasis>, cocci in pairs and short chains; (D) <emphasis>Aerococcus urinae</emphasis>, cocci in clusters; (E) <emphasis>Aerococcus sanguinicola</emphasis>, cocci in clusters with larger cell size than <emphasis>A. urinae</emphasis>; (F) <emphasis>Leuconostoc mesenteroides</emphasis>, coccobacilli in pairs and short chains; (G) <emphasis>Dolosigranulum pigrum</emphasis>, cocci in pairs and tetrads; (H) <emphasis>Ignavigranum ruoffiae</emphasis>, cocci in pairs and short chains; (I) <emphasis>Helcococcus kunzii</emphasis>, cocci predominantly in clusters; (J) <emphasis>Lactococcus lactis</emphasis>, cocci in pairs and short chains; (K) <emphasis>Pediococcus pentosaceus</emphasis>, cocci in pairs, tetrads, short chains, and clusters.
</title>
          
          <mediaobject>
            <imageobject>
              <imagedata fileref="Ch0040f03.jpg" width="100%" scalefit="1"/>
            </imageobject>
          </mediaobject>
        </figure>
      </sect2>
    </sect1>
    <sect1 id="ch0040s0017">
      <title>Commercially Available Kits and Automated Methods Based on Phenotypic Traits</title>
      <anchor id="ch0040s0017a0001"/>
      <anchor id="ch0040s0017a0002"/>
      <para id="ch0040s0017p0001">There have been no comprehensive evaluations of the ability of commercially available products to identify the diverse and infrequently isolated bacteria described in this chapter. Phenotypic variation among isolates classified in the same species, the relative metabolic inactivity of some organisms, and a relatively small number of strains available for inclusion in databases have challenged the capabilities of these products for accurate identification. Manual methods for performance of some of the basic differentiation tests (e.g., PYR and LAP) are available (e.g., Remel BactiCard Strep; Thermo Fisher Scientific). Commercially available identification kits or systems offering a more comprehensive array of phenotypic tests are improving in their ability to identify many of the organisms discussed in this chapter (<link linkend="ch0040s0018s0007li0028">28</link>, <link linkend="ch0040s0018s0007li0114">114</link>, <link linkend="ch0040s0018s0007li0116">116</link>–<link linkend="ch0040s0018s0007li0118">118</link>). These products include manual methods, e.g., API 20 Strep, and automated systems, e.g., VITEK 2 (bioMérieux), MicroScan (Beckman Coulter, Brea, CA), and Phoenix (BD, Franklin Lakes, NJ). In the absence of an accurate genus- or species-level identification, these systems will at least provide additional phenotypic information that can be used to augment results of the basic tests mentioned above.</para>
      <anchor id="ch0040s0017a0003"/>
      <beginpage pagenum="478"/>
    </sect1>
    <sect1 id="ch0040s0018">
      <title>Molecular Methods</title>
      <anchor id="ch0040s0018a0001"/>
      <anchor id="ch0040s0018a0002"/>
      <sect2 id="ch0040s0018s0001">
        <title>Sequence-Based Techniques</title>
        <anchor id="ch0040s0018s0001a0001"/>
        <anchor id="ch0040s0018s0001a0002"/>
        <para id="ch0040s0018s0001p0001">16S rRNA gene sequencing-based identifications have proven to be more accurate than phenotypic methods for identifying many of the infrequently isolated aerobic catalase-negative, Gram-positive cocci (<link linkend="ch0040s0018s0007li0116">116</link>, <link linkend="ch0040s0018s0007li0118">118</link>). Bosshard and colleagues (<link linkend="ch0040s0018s0007li0116">116</link>) analyzed 171 clinical strains of the genera <emphasis>Streptococcus, Enterococcus, Abiotrophia, Aerococcus, Granulicatella</emphasis>, and <emphasis>Gemella</emphasis> and observed that more species- or genus-level identifications were achieved via 16S rRNA gene sequence analysis than by a commercially available phenotypic method (API 20 Strep). Identifications based on phenotypic traits often disagreed with those determined by 16S rRNA gene sequencing. Woo and coworkers (<link linkend="ch0040s0018s0007li0118">118</link>) examined strains of <emphasis>Abiotrophia, Granulicatella, Gemella</emphasis>, and <emphasis>Helcococcus</emphasis> in their evaluation of a commercially available 16S rRNA gene sequence-based identification system that analyzes a 527-bp fragment of the 16S rRNA gene (MicroSeq 500; Life Technologies, Foster City, CA). They noted disagreement in identifications obtained with commercially available phenotypic test systems (API 20 Strep and VITEK) and MicroSeq 500 compared with conventional sequencing of the entire 16S rRNA gene. The authors stressed the importance of adequate databases for accurate rRNA gene sequence-based identification. Different regions of the 16S rRNA gene have been used for identification. The first 500 bp is the most commonly applied target for identification (<link linkend="ch0040s0018s0007li0119">119</link>). The entire 16S rRNA gene (1.5 kb) has also been sequenced when more-detailed descriptions of taxa or strains are being made (<link linkend="ch0040s0018s0007li0120">120</link>). 16S rRNA gene sequencing is an effective method for identifying the genera included in this chapter, many of which are difficult to identify with conventional phenotypic methods (<link linkend="ch0040s0018s0007li0120">120</link>, <link linkend="ch0040s0018s0007li0121">121</link>). Accumulating data on the clinical significance of species make it possible to link an accurate species identification to clinically relevant information (<link linkend="ch0040s0018s0007li0120">120</link>). Other reports on identification of strains of the genera <emphasis>Aerococcus, Granulicatella</emphasis>, and <emphasis>Globicatella</emphasis> support the benefits of using 16S rRNA gene sequencing for these genera (<link linkend="ch0040s0018s0007li0042">42</link>, <link linkend="ch0040s0018s0007li0122">122</link>–<link linkend="ch0040s0018s0007li0125">125</link>).</para>
        <para id="ch0040s0018s0001p0002">Broad-range amplification of the 16S rRNA gene directly from clinical samples has made it possible to detect taxa described in this chapter from various clinical samples yielding no growth in culture (for instance,<emphasis>G. elegans</emphasis> and <emphasis>A. urinae</emphasis> from cardiac valvular tissue [126, 127]). A major challenge for this methodology when the Sanger method is used is the difficulty in analyzing sequence data when multiple bacterial species are present in the same specimen. Kommedal and coworkers used a set of group-specific, broad-range primers targeting the 16S rRNA gene followed by DNA sequencing and RipSeq analysis (iSentio AS, Paradis, Norway) and identified <emphasis>Gemella</emphasis> species from abscess material also containing bacterial DNA from other taxa (<link linkend="ch0040s0018s0007li0128">128</link>). When clinical samples are being examined, cross-reactivity with human DNA is a major pitfall that can result in mixed electropherograms, complicating subsequent sequence analysis and species identification. Kommedal and colleagues employed the principle of dual-priming oligonucleotides to circumvent cross-reactivity even in specimens with a high ratio of human to bacterial DNA (<link linkend="ch0040s0018s0007li0129">129</link>).</para>
        <para id="ch0040s0018s0001p0003">Alternative sequencing targets for identification of the organisms discussed in this chapter have also been explored. PCR amplification of a 740-bp<emphasis>rpoB</emphasis> gene fragment followed by sequence analysis was shown to be a suitable molecular approach for the species-level identification of <emphasis>Streptococcus, Enterococcus, Gemella, Abiotrophia</emphasis>, and <emphasis>Granulicatella</emphasis> isolates by Drancourt and colleagues (<link linkend="ch0040s0018s0007li0130">130</link>). Hung et al. (<link linkend="ch0040s0018s0007li0131">131</link>) determined the <emphasis>groESL</emphasis> sequences of three species of nutritionally variant streptococci and three <emphasis>Gemella</emphasis> species and developed a multiplex PCR enabling identification of strains of <emphasis>Abiotrophia, Granulicatella</emphasis>, and <emphasis>Gemella</emphasis> at the genus level. To a large extent, intraspecies sequences were well circumscribed, though higher intraspecies heterogeneity was observed in <emphasis>G. haemolysans</emphasis>, with the six isolates examined being separated into two subgroups.</para>
        <para id="ch0040s0018s0001p0004">Tung and coworkers (<link linkend="ch0040s0018s0007li0132">132</link>) evaluated the feasibility of sequence analysis of the ribosomal 16S-23S intergenic spacer region (ITS) for identification of 24 species of <emphasis>Streptococcus</emphasis>, 1 species of <emphasis>Abiotrophia</emphasis>, 18 species of <emphasis>Enterococcus</emphasis>, and 3 species of <emphasis>Granulicatella</emphasis>. The rate of correct species identification by ITS sequence analysis was 98.2%. However, all of the genera except <emphasis>Streptococcus</emphasis> produced more than one PCR amplicon, necessitating agarose gel separation and in some cases cloning to purify the amplicons before sequencing. Tung and colleagues (<link linkend="ch0040s0018s0007li0133">133</link>) further developed an array-based identification setup based on PCR amplification of the ITS regions and found it to be a useful and reliable alternative to phenotypic identification methods. The approach of having a single molecular platform for strains resembling nonhemolytic streptococci, enterococci, and the taxa considered in this chapter based on ITS analysis has also been examined by Nielsen and colleagues (<link linkend="ch0040s0018s0007li0134">134</link>). Clinical strains of the genera <emphasis>Aerococcus</emphasis> (<emphasis>n</emphasis> = 37), <emphasis>Abiotrophia</emphasis> (<emphasis>n</emphasis> = 2), <emphasis>Granulicatella</emphasis> (<emphasis>n</emphasis> = 9), <emphasis>Gemella</emphasis> (<emphasis>n</emphasis> = 22), and <emphasis>Leuconostoc</emphasis> (<emphasis>n</emphasis> = 5) were examined. All 75 clinical strains, irrespective of the maximum score obtained, were allocated to the expected species except for two strains of <emphasis>Gemella</emphasis>.</para>
        <para id="ch0040s0018s0001p0005">Phylogeny, identification, and virulence characterization based on whole-genome sequence (WGS) data or extracts thereof are and will be increasingly possible and available for many taxa with the rapidly increasing use of next-generation sequencing technology (see<ulink url="ch0023#ch0023s0001">chapter 8</ulink>). Whole-genome sequences from all genera and species mentioned in this chapter as having been recognized as clinically significant for humans can be retrieved from <ulink url="https://www.ncbi.nlm.nih.gov/genome/">https://www.ncbi.nlm.nih.gov/genome/</ulink>. However, the WGS workflow needs to be improved further to be implemented as a routine method for identification of the species mentioned in this chapter.</para>
      </sect2>
      <sect2 id="ch0040s0018s0002">
        <title>MALDI-TOF MS Techniques</title>
        <anchor id="ch0040s0018s0002a0001"/>
        <anchor id="ch0040s0018s0002a0002"/>
        <para id="ch0040s0018s0002p0001">MALDI-TOF MS (see<ulink url="ch0021#ch0021s0001">chapter 6</ulink>) for analysis of bacterial proteins is a promising technique for identification of the bacteria mentioned in this chapter. In <ulink url="ch0036#ch0036s0001s0001a0006">Tables 1</ulink> and <ulink url="ch0036#ch0036s0001s0001a0023">2</ulink> of <ulink url="ch0036#ch0036s0001s0001">chapter 20</ulink>, a number of genera and species included in the most recently updated <emphasis>in vitro</emphasis> diagnostic databases from Bruker and bioMérieux are given; research-use-only databases exist for both systems. The mass spectrometry setups are constantly being improved, and the misidentification rate for even rare and seldom-seen taxa is low and diminishing. Christensen and coworkers (<link linkend="ch0040s0018s0007li0135">135</link>) examined 51 culture collection strains and 90 well-characterized strains with the Bruker Biotyper system. A mass spectrum profile (MSP) based on 24 separate determinations was created for each strain and stored in a separate library that could be combined with the standard database (Biotyper version 2.0.43.1), which did not include all the taxa examined. The following genera were represented: <emphasis>Aerococcus</emphasis> (<emphasis>n</emphasis> = 42), <emphasis>Gemella</emphasis> (<emphasis>n</emphasis> = 30), <emphasis>Granulicatella</emphasis> (<emphasis>n</emphasis> = 11), <emphasis>Abiotrophia</emphasis> (<emphasis>n</emphasis> = 3), <emphasis>Lactococcus</emphasis> (<emphasis>n</emphasis> = 9), <emphasis>Globicatella</emphasis> (<emphasis>n</emphasis> = 7), <emphasis>Leuconostoc</emphasis> (<emphasis>n</emphasis> = 9), <emphasis>Rothia</emphasis> (<emphasis>n</emphasis> = 9), <emphasis>Facklamia</emphasis> (<emphasis>n</emphasis> = 7), <emphasis>Vagococcus</emphasis> (<emphasis>n</emphasis> = 2), <emphasis>Helcococcus</emphasis> (<emphasis>n</emphasis> = 4), <emphasis>Alloiococcus</emphasis> (<emphasis>n</emphasis> = 2), <emphasis>Pediococcus</emphasis> (<emphasis>n</emphasis> = 3), <emphasis>Ignavigranum</emphasis> (<emphasis>n</emphasis> = 1), <emphasis>Dolosicoccus</emphasis> (<emphasis>n</emphasis> = 1), and <emphasis>Dolosigranulum</emphasis> (<emphasis>n</emphasis> = 1). The protocol for creating one’s own MSPs in a separate library, though somewhat labor-intensive, makes it possible to extend the database. After extension of the database, all challenge strains were correctly identified to the species level except for a few difficult-to-identify <emphasis>Gemella</emphasis> strains. The mean scores obtained illustrated diversity within the different species and an effect on mean scores of different conditions for creating MSPs. The MSP dendrograms for <emphasis>Aerococcus, Gemella, Granulicatella</emphasis>, and <emphasis>Abiotrophia</emphasis> convincingly delineated the included species. Thus, for routine use, MALDI-TOF MS was shown to be robust. In a study by Rychert et al., 1,146 strains of Gram-positive cocci were examined with the VITEK MS version 2.0 system (<link linkend="ch0040s0018s0007li0136">136</link>). Fifteen of these strains belonged to taxa described in this chapter: <emphasis>A. defectiva</emphasis> (<emphasis>n</emphasis> = 2), <emphasis>A. viridans</emphasis> (<emphasis>n</emphasis> = 6), <emphasis>G. haemolysans</emphasis> (<emphasis>n</emphasis> = 3), <emphasis>G. adiacens</emphasis> (<emphasis>n</emphasis> = 1), <emphasis>L. garvieae</emphasis> (<emphasis>n</emphasis> = 1), <emphasis>L. lactis</emphasis> (<emphasis>n</emphasis> = 1), and <emphasis>L. mesenteroides</emphasis> (<emphasis>n</emphasis> = 1). All strains were correctly identified except the <emphasis>L. mesenteroides</emphasis> strain, which gave no identification. Other studies have corroborated the usefulness of MALDI-TOF MS for identification of aerococci (<link linkend="ch0040s0018s0007li0137">137</link>), <emphasis>Lactococcus</emphasis> species (<link linkend="ch0040s0018s0007li0138">138</link>, <link linkend="ch0040s0018s0007li0139">139</link>), and <emphasis>Leuconostoc</emphasis> (<link linkend="ch0040s0018s0007li0139">139</link>) species and have investigated using this technique for identification of <emphasis>Weissella</emphasis> and <emphasis>Pediococcus</emphasis> strains (<link linkend="ch0040s0018s0007li0140">140</link>).</para>
        <anchor id="ch0040s0018s0002a0003"/>
        <beginpage pagenum="479"/>
      </sect2>
      <sect2 id="ch0040s0018s0003">
        <title>TYPING SYSTEMS</title>
        <anchor id="ch0040s0018s0003a0001"/>
        <anchor id="ch0040s0018s0003a0002"/>
        <para id="ch0040s0018s0003p0001">Little information exists on typing methods for the genera of infrequently isolated Gram-positive cocci included in this chapter. Typing is not routinely used for characterizing these organisms. If needed, typing could be done by DNA sequence analysis (<link linkend="ch0040s0018s0007li0141">141</link>).</para>
      </sect2>
      <sect2 id="ch0040s0018s0004">
        <title>SEROLOGIC TESTS</title>
        <anchor id="ch0040s0018s0004a0001"/>
        <anchor id="ch0040s0018s0004a0002"/>
        <para id="ch0040s0018s0004p0001">The serologic response to the organisms described in this chapter has not been extensively investigated. No clinically useful tests have been described.</para>
      </sect2>
      <sect2 id="ch0040s0018s0005">
        <title>ANTIMICROBIAL SUSCEPTIBILITIES</title>
        <anchor id="ch0040s0018s0005a0001"/>
        <anchor id="ch0040s0018s0005a0002"/>
        <para id="ch0040s0018s0005p0001">Antimicrobial susceptibility studies on the organisms mentioned in this chapter have generally employed dilution testing methods. Few or no data exist on the utility of disk diffusion or the correlation of Etest results with those of broth or agar dilution methods. Standardized dilution methods and interpretive criteria for observed MICs have been described by the Clinical and Laboratory Standards Institute (CLSI) for seven of the genera (<emphasis>Aerococcus, Abiotrophia, Gemella, Granulicatella, Lactococcus, Leuconostoc</emphasis>, and <emphasis>Pediococcus</emphasis> [142] [see <ulink url="ch0095#ch0095s0001">chapter 77</ulink>]). EUCAST recommendations for <emphasis>A. urinae</emphasis> and <emphasis>A. sanguinicola</emphasis> were included in 2017 (<link linkend="ch0040s0018s0007li0143">143</link>). The lack of standardized methods and interpretive criteria and the relatively small collections of isolates for some of the genera discussed in this chapter make it difficult to accurately assess antimicrobial susceptibility patterns. With the exception of <emphasis>Leuconostoc, Pediococcus</emphasis>, and <emphasis>Weissella</emphasis>, all of the genera display susceptibility to vancomycin. While many of the genera are susceptible to β-lactams and other antimicrobials, observed strain variations suggest that MICs of antimicrobials used for treatment should be determined for individual isolates. When susceptibility testing is requested for isolates for which no guidelines exist, dilution methods may be used to generate MICs that can be reported without interpretation. The laboratory should discuss the implications of nonstandardized susceptibility testing results with the requesting physician. Since many of the bacteria discussed here are fastidious, investigators have often employed blood-supplemented Mueller-Hinton media and, if necessary for good growth, incubation in a CO<subscript>2</subscript>-enriched atmosphere for susceptibility testing. Pyridoxal hydrochloride (final concentration of 0.001%) should also be added to blood-supplemented media for testing strains of <emphasis>Abiotrophia</emphasis> and <emphasis>Granulicatella</emphasis> (<link linkend="ch0040s0018s0007li0142">142</link>). Details of published susceptibility testing studies for each of the genera appear below.</para>
        <para id="ch0040s0018s0005p0002">Information on the<emphasis>in vitro</emphasis> antimicrobial susceptibility of <emphasis>L. lactis</emphasis> and <emphasis>L. garvieae</emphasis> strains isolated from humans suggests that <emphasis>L. garvieae</emphasis> isolates are less susceptible to penicillin and cephalothin than are strains of <emphasis>L. lactis</emphasis>. The uniform resistance of <emphasis>L. garvieae</emphasis> to clindamycin versus the uniform susceptibility of the <emphasis>L. lactis</emphasis> strains examined by Elliott and Facklam (<link linkend="ch0040s0018s0007li0115">115</link>) led them to propose a test for clindamycin susceptibility as an aid in differentiation of these two species. Teixeira and colleagues (<link linkend="ch0040s0018s0007li0099">99</link>) observed that a collection of <emphasis>Vagococcus</emphasis> isolates were all susceptible to ampicillin, cefotaxime, and trimethoprim-sulfamethoxazole. All strains were resistant to clindamycin, lomefloxacin, and ofloxacin. Variable results were observed with other antimicrobial agents (<link linkend="ch0040s0018s0007li0099">99</link>).</para>
        <para id="ch0040s0018s0005p0003">The vancomycin-resistant genera<emphasis>Leuconostoc</emphasis> and <emphasis>Pediococcus</emphasis> are penicillin susceptible when MICs are interpreted by using criteria for <emphasis>Enterococcus</emphasis> spp. (<link linkend="ch0040s0018s0007li0142">142</link>, <link linkend="ch0040s0018s0007li0144">144</link>). They are usually susceptible to chloramphenicol, tetracyclines, and aminoglycosides. Carbapenem and cephalosporin resistance has been noted in some strains of <emphasis>Leuconostoc</emphasis> (<link linkend="ch0040s0018s0007li0091">91</link>). Huang and colleagues (<link linkend="ch0040s0018s0007li0145">145</link>) noted MIC ranges of 0.5 to 8 μg/ml for linezolid and 0.06 to 2 μg/ml for daptomycin in 68 strains of <emphasis>Leuconostoc</emphasis> and ranges of 1 to 4 μg/ml for linezolid and 0.06 to 0.5 μg/ml for daptomycin in 13 <emphasis>Pediococcus</emphasis> isolates. Iwen and colleagues reported the successful treatment of a case of <emphasis>P. acidilactici</emphasis> endocarditis with daptomycin (<link linkend="ch0040s0018s0007li0146">146</link>).</para>
        <para id="ch0040s0018s0005p0004">Susceptibility data on<emphasis>Abiotrophia</emphasis> and <emphasis>Granulicatella</emphasis> isolates are accumulating. Data on series of 39 (<link linkend="ch0040s0018s0007li0147">147</link>), 132 (<link linkend="ch0040s0018s0007li0148">148</link>), 134 (<link linkend="ch0040s0018s0007li0149">149</link>), and 599 (<link linkend="ch0040s0018s0007li0150">150</link>) isolates have been published in more recent years. Approximately 70 to 85% of isolates belonged to <emphasis>G. adiacens</emphasis>, 20 to 30% belonged to <emphasis>A. defectiva</emphasis>, and only relatively few isolates belonged to <emphasis>G. elegans</emphasis> (up to 20 isolates [150]). Studies have demonstrated the same trends in susceptibility patterns. Broth microdilution MIC determinations as well as the Etest method have been employed. However, in the study by Alberti et al. (<link linkend="ch0040s0018s0007li0151">151</link>) on 125 <emphasis>Abiotrophia</emphasis> and <emphasis>Granulicatell</emphasis>a strains, the Etest performed poorly with vancomycin and, although to a lesser extent, with penicillin and ceftriaxone. Only 10 to 14% of <emphasis>A. defectiva</emphasis> and 34 to 44% of <emphasis>G. adiacens</emphasis> isolates were recorded as susceptible to penicillin. Interestingly, <emphasis>G. elegans</emphasis> isolates were significantly more susceptible to penicillin, as 80% (16/20) of isolates in the study by Prasidthrathsint and Fisher (<link linkend="ch0040s0018s0007li0150">150</link>) were susceptible. Among penicillin-susceptible <emphasis>G. adiacens</emphasis> isolates, only 65% were susceptible to ceftriaxone, and of the penicillin-resistant isolates, 95% were also resistant to ceftriaxone (<link linkend="ch0040s0018s0007li0150">150</link>). In the studies by Alberti et al. and Mushtaq et al. (<link linkend="ch0040s0018s0007li0148">148</link>, <link linkend="ch0040s0018s0007li0149">149</link>), only 22 to 44% of <emphasis>G. adiacens</emphasis> isolates were susceptible to ceftriaxone. Prasidthrathsint and Fisher (<link linkend="ch0040s0018s0007li0150">150</link>) found that the majority of penicillin-susceptible <emphasis>A. defectiva</emphasis> isolates (95%) remained susceptible to ceftriaxone, whereas 97% of penicillin-resistant <emphasis>A. defectiva</emphasis> isolates remained susceptible to ceftriaxone. In the studies by Alberti et al. and Mushtaq et al. on <emphasis>A. defectiva</emphasis> isolates, 92 to 100% of isolates were susceptible to ceftriaxone. Reduced susceptibility to meropenem has been observed for 10 and 20% of <emphasis>G. adiacens</emphasis> and <emphasis>A. defectiva</emphasis> isolates, respectively, and MICs of ≥2 μg/ml have been observed for 2.4% and 0.6% of isolates, respectively (<link linkend="ch0040s0018s0007li0150">150</link>).</para>
        <anchor id="ch0040s0018s0005a0003"/>
        <beginpage pagenum="480"/>
        <para id="ch0040s0018s0005p0005">Susceptibility to aminoglycosides is also variable for<emphasis>Abiotrophia</emphasis> and <emphasis>Granulicatella</emphasis>, but no cases of high-level resistance have been reported. Treatment regimens for infective endocarditis outlined for <emphasis>A. defectiva</emphasis> and <emphasis>Granulicatella</emphasis> species are subdivided into categories based on penicillin MIC data (<link linkend="ch0040s0018s0007li0152">152</link>). Macrolide resistance, especially to erythromycin, has been documented in several studies, though one study found that all 39 strains were susceptible (<link linkend="ch0040s0018s0007li0147">147</link>, <link linkend="ch0040s0018s0007li0148">148</link>, <link linkend="ch0040s0018s0007li0150">150</link>, <link linkend="ch0040s0018s0007li0153">153</link>). Strains have tested susceptible to rifampin and quinupristin-dalfopristin (<link linkend="ch0040s0018s0007li0147">147</link>), and most strains have tested susceptible to the quinolones levofloxacin and ofloxacin (<link linkend="ch0040s0018s0007li0147">147</link>, <link linkend="ch0040s0018s0007li0150">150</link>), though resistant strains have occurred (<link linkend="ch0040s0018s0007li0148">148</link>, <link linkend="ch0040s0018s0007li0150">150</link>). Daptomycin MICs have ranged from ≤0.125 to &gt;4 μg/ml (<link linkend="ch0040s0018s0007li0148">148</link>, <link linkend="ch0040s0018s0007li0154">154</link>); in the study by Alberti and coworkers, the MIC<subscript>90</subscript> was &gt;4 μg/ml for strains of <emphasis>G. adiacens</emphasis> and <emphasis>A. defectiva</emphasis>. Five <emphasis>G. elegans</emphasis> isolates tested 100% susceptible to 14 antimicrobials, with the exception of erythromycin, to which only one strain was susceptible.</para>
        <para id="ch0040s0018s0005p0006"><emphasis>A. viridans</emphasis> and <emphasis>G. haemolysans</emphasis> appear to be susceptible to penicillin and display a low level of resistance to aminoglycosides (<link linkend="ch0040s0018s0007li0155">155</link>, <link linkend="ch0040s0018s0007li0156">156</link>). Resistance to tetracycline and macrolides in <emphasis>Gemella</emphasis> isolates has been described (<link linkend="ch0040s0018s0007li0157">157</link>), as well as a synergistic effect for penicillin and gentamicin (<link linkend="ch0040s0018s0007li0156">156</link>). Piper and colleagues (<link linkend="ch0040s0018s0007li0154">154</link>) noted daptomycin MICs of ≤0.125 μg/ml for four strains of <emphasis>G. morbillorum</emphasis>. Buu-Hoi and colleagues (<link linkend="ch0040s0018s0007li0155">155</link>) noted that while <emphasis>A. viridans</emphasis> seems to be naturally susceptible to macrolides, tetracyclines, and chloramphenicol, resistance to these agents has been observed. <emphasis>A. urinae</emphasis> has been described as susceptible to penicillin, amoxicillin, piperacillin, cefepime, rifampin, and nitrofurantoin but resistant to sulfonamides and netilmicin (<link linkend="ch0040s0018s0007li0112">112</link>, <link linkend="ch0040s0018s0007li0158">158</link>, <link linkend="ch0040s0018s0007li0159">159</link>). Humphries and coworkers (<link linkend="ch0040s0018s0007li0160">160</link>) noted that <emphasis>A. urinae</emphasis>’s resistance to trimethoprim-sulfamethoxazole is test medium dependent. Strains of this organism are susceptible to trimethoprim-sulfamethoxazole when tested on media that contain lysed horse blood and display low levels of thymidine. <emphasis>A. sanguinicola</emphasis> isolates display susceptibility to penicillin, amoxicillin, cefotaxime, cefuroxime, erythromycin, chloramphenicol, quinupristin-dalfopristin, rifampin, linezolid, and tetracycline (<link linkend="ch0040s0018s0007li0028">28</link>).</para>
        <para id="ch0040s0018s0005p0007">Clinical isolates of<emphasis>D. pigrum</emphasis> studied by Laclaire and Facklam (<link linkend="ch0040s0018s0007li0024">24</link>) were all susceptible to penicillin, amoxicillin, cefotaxime, cefuroxime, clindamycin, levofloxacin, meropenem, quinupristin-dalfopristin, rifampin, and tetracycline. Variable susceptibility to erythromycin was noted, and 1 of the 27 strains examined was resistant to trimethoprim-sulfamethoxazole.</para>
        <para id="ch0040s0018s0005p0008"><emphasis>Helcococcus</emphasis> infections have been treated with amoxicillin-clavulanate, fluoroquinolones, and third-generation cephalosporins, but comprehensive data on antimicrobial susceptibilities of these organisms are lacking (<link linkend="ch0040s0018s0007li0082">82</link>). Recently, Guérin and coworkers (<link linkend="ch0040s0018s0007li0161">161</link>) described a novel chromosomeal <emphasis>erm</emphasis>(<link linkend="ch0040s0018s0007li0047">47</link>) determinant responsible for constitutive macrolide-lincosamide-streptogramin B resistance in <emphasis>Helcococcus kunzii</emphasis>. Strains of <emphasis>Facklamia</emphasis> exhibit variable MICs for a variety of antibiotics. LaClaire and Facklam (<link linkend="ch0040s0018s0007li0162">162</link>) investigated antimicrobial susceptibility for 15 antimicrobial agents using a microdilution method on 18 strains of the <emphasis>Facklamia</emphasis> species from human samples. While 83% of the strains were susceptible to penicillin (MIC ≤ 0.12 μg/ml), only 54% were susceptible to cefotaxime (MIC ≤ 1 μg/ml) and 67% were susceptible to cefuroxime. Differences in susceptibilities among <emphasis>Facklamia</emphasis> species were observed, too. A study of 27 strains of <emphasis>Globicatella sanguinis</emphasis> investigated 12 antimicrobial agents using a microdilution method. All isolates had low MICs and were susceptible to amoxicillin (MIC ≤ 0.03 μg/ml) and vancomycin (MIC ≤ 0.12 μg/ml). The MIC range for penicillin was ≤0.03 to 0.50 μg/ml, and two strains were intermediate to penicillin according to CLSI breakpoints. However, the MICs of cephalosporins were higher than those of penicillins. Forty-eight percent of strains were resistant to cefotaxime (MIC range, 0.06 to 4.0 μg/ml) and 74% of strains were resistant to cefuroxime (MIC range, 0.12 to 16). Various levels of resistance to other antimicrobial agents tested were observed; for instance, 37% were resistant to meropenem, and 48% were resistant to erythromycin (<link linkend="ch0040s0018s0007li0163">163</link>).</para>
      </sect2>
      <sect2 id="ch0040s0018s0006">
        <title>EVALUATION, INTERPRETATION, AND REPORTING OF RESULTS</title>
        <anchor id="ch0040s0018s0006a0001"/>
        <anchor id="ch0040s0018s0006a0002"/>
        <para id="ch0040s0018s0006p0001">Efforts to identify the Gram-positive cocci included in this chapter should be made only when isolates are considered clinically significant (i.e., isolated repeatedly, in pure culture, or from normally sterile sites), since these organisms may also appear in clinical cultures as contaminants or constituents of the normal microbiota. Communication with clinicians should guide the microbiology laboratory in evaluating the significance of these infrequently isolated organisms. The phenotypic tests mentioned in<link linkend="ch0040s0001s0001a0005">Table 1</link> and <link linkend="ch0040s0016a0008">Fig. 1</link> and <link linkend="ch0040s0016a0010">2</link> facilitate presumptive identification of the infrequently isolated catalase-negative, Gram-positive cocci. More extensive phenotypic testing using commercially available identification systems and molecular methods should be employed for definitive identification. Currently, there are susceptibility testing guidelines for only seven of the genera mentioned in this chapter. The MICs generated with dilution methods can be reported without interpretation when susceptibility testing is requested for significant isolates for which no guidelines exist.</para>
        <para id="ch0040s0018s0006p0002"><emphasis>Abiotrophia, Granulicatella</emphasis>, and <emphasis>Gemella</emphasis> species are well-documented agents of endocarditis. The satelliting behavior of <emphasis>Abiotrophia</emphasis> and <emphasis>Granulicatella</emphasis> and the positive PYR reactions of all three genera are useful for distinguishing them from viridans-group streptococci. CLSI guidelines (<link linkend="ch0040s0018s0007li0142">142</link>) should be employed for susceptibility testing and interpretation of results for <emphasis>Abiotrophia</emphasis> and <emphasis>Granulicatella</emphasis>. The vancomycin-resistant genera <emphasis>Leuconostoc, Pediococcus</emphasis>, and <emphasis>Weissella</emphasis> are infrequent clinical isolates, but they have been described as agents of bacteremia and central nervous system and other infections in compromised hosts. Phenotypic testing for vancomycin resistance (see “Identification” above) is important for identifying these genera and also helps guide antimicrobial therapy. Guidelines for antimicrobial susceptibility testing and interpretation of results are available for <emphasis>Leuconostoc</emphasis> and <emphasis>Pediococcus</emphasis> (<link linkend="ch0040s0018s0007li0142">142</link>). Among the aerococci, <emphasis>A. urinae</emphasis> and <emphasis>A. sanguinicola</emphasis> are well-documented urinary tract pathogens and should be reported when isolated in significant amounts as the predominant organism in urine cultures. Phenotypic tests mentioned in this chapter presumptively identify <emphasis>A. urinae</emphasis>, which has been described as susceptible to β-lactam agents and nitrofurantoin (<link linkend="ch0040s0018s0007li0112">112</link>, <link linkend="ch0040s0018s0007li0158">158</link>).</para>
        <anchor id="ch0040s0018s0006a0003"/>
        <beginpage pagenum="481"/>
        <para id="ch0040s0018s0006p0003">We acknowledge Jens Ole Eriksen and Michael Bzoryk for producing microscopic pictures for<link linkend="ch0040s0016s0008a0005">Fig. 3</link>.</para>
      </sect2>
      <sect2 id="ch0040s0018s0007">
        <title>REFERENCES</title>
        <anchor id="ch0040s0018s0007a0001"/>
        <anchor id="ch0040s0018s0007a0002"/>
        <itemizedlist mark="none" role="biblioEntryList">
          <listitem id="ch0040s0018s0007li0001" role="bibliographyEntry">
            <para>1.<emphasis role="strong">Ludwig W, Schleifer KH, Whitman WB.</emphasis> 2009. Revised road map to the phylum <emphasis><citetitle>Firmicutes</citetitle></emphasis>, p 1–17. <emphasis><citetitle>In</citetitle></emphasis> Vos P, Garrity GM, Jones D, Krieg NR, Ludwig W, Rainey FA, Schleifer KH, Whitman WB (ed), <emphasis><citetitle>Bergey’s Manual of Systematic Bacteriology</citetitle></emphasis>, 2nd ed, vol 3. Springer-Verlag, New York, NY.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0002" role="bibliographyEntry">
            <para>2.<emphasis role="strong">Mattarelli P, Holzapfel W, Franz CMAP, Endo A, Felis GE, Hammes W, Pot B, Dicks L, Dellaglio F.</emphasis> 2014. Recommended minimal standards for description of new taxa of the genera <emphasis><citetitle>Bifidobacterium</citetitle>, <citetitle>Lactobacillus</citetitle></emphasis> and related genera. <emphasis><citetitle>Int J Syst Evol Microbiol</citetitle></emphasis> <emphasis role="strong">64:</emphasis>1434–1451.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0003" role="bibliographyEntry">
            <para>3.<emphasis role="strong">Schleifer KH, Kraus J, Dvorak C, Kilpper-Bälz R, Collins MD, Fischer W.</emphasis> 1985. Transfer of <emphasis><citetitle>Streptococcus lactis</citetitle></emphasis> and related streptococci to the genus <emphasis><citetitle>Lactococcus</citetitle></emphasis> gen. nov. <emphasis><citetitle>Syst Appl Microbiol</citetitle></emphasis> <emphasis role="strong">6:</emphasis>183–195.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0004" role="bibliographyEntry">
            <para>4.<emphasis role="strong">Collins MD, Ash C, Farrow JA, Wallbanks S, Williams AM.</emphasis> 1989. 16S ribosomal ribonucleic acid sequence analyses of lactococci and related taxa. Description of <emphasis><citetitle>Vagococcus fluvialis</citetitle></emphasis> gen. nov., sp. nov. <emphasis><citetitle>J Appl Bacteriol</citetitle></emphasis> <emphasis role="strong">67:</emphasis>453–460.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0005" role="bibliographyEntry">
            <para>5.<emphasis role="strong">Matsuo T, Mori N, Kawai F, Sakurai A, Toyoda M, Mikami Y, Uehara Y, Furukawa K.</emphasis> 2021. <emphasis><citetitle>Vagococcus fluvialis</citetitle></emphasis> as a causative pathogen of bloodstream and decubitus ulcer infection: case report and systematic review of the literature. <emphasis><citetitle>J Infect Chemother</citetitle></emphasis> <emphasis role="strong">27:</emphasis>359–363.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0006" role="bibliographyEntry">
            <para>6.<emphasis role="strong">Shewmaker PL, Whitney AM, Gulvik CA, Humrighouse BW, Gartin J, Moura H, Barr JR, Moore ERB, Karlsson R, Pinto TCA, Teixeira LM.</emphasis> 2019. <emphasis><citetitle>Vagococcus bubulae</citetitle></emphasis> sp. nov., isolated from ground beef, and <emphasis><citetitle>Vagococcus vulneris</citetitle></emphasis> sp. nov., isolated from a human foot wound. <emphasis><citetitle>Int J Syst Evol Microbiol</citetitle></emphasis> <emphasis role="strong">69:</emphasis>2268–2276.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0007" role="bibliographyEntry">
            <para>7.<emphasis role="strong">Facklam R, Elliott JA.</emphasis> 1995. Identification, classification, and clinical relevance of catalase-negative, gram-positive cocci, excluding the streptococci and enterococci. <emphasis><citetitle>Clin Microbiol Rev</citetitle></emphasis> <emphasis role="strong">8:</emphasis>479–495.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0008" role="bibliographyEntry">
            <para>8.<emphasis role="strong">Collins MD, Lawson PA.</emphasis> 2000. The genus <emphasis><citetitle>Abiotrophia</citetitle></emphasis> (Kawamura et al.) is not monophyletic: proposal of <emphasis><citetitle>Granulicatella</citetitle></emphasis> gen. nov., <emphasis><citetitle>Granulicatella adiacens</citetitle></emphasis> comb. nov., <emphasis><citetitle>Granulicatella elegans</citetitle></emphasis> comb. nov. and <emphasis><citetitle>Granulicatella balaenopterae</citetitle></emphasis> comb. nov. <emphasis><citetitle>Int J Syst Evol Microbiol</citetitle></emphasis> <emphasis role="strong">50:</emphasis>365–369.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0009" role="bibliographyEntry">
            <para>9.<emphasis role="strong">Kawamura Y, Hou XG, Sultana F, Liu S, Yamamoto H, Ezaki T.</emphasis> 1995. Transfer of <emphasis><citetitle>Streptococcus adjacens</citetitle></emphasis> and <emphasis><citetitle>Streptococcus defectivus</citetitle></emphasis> to <emphasis><citetitle>Abiotrophia</citetitle></emphasis> gen. nov. as <emphasis><citetitle>Abiotrophia adiacens</citetitle></emphasis> comb. nov. and <emphasis><citetitle>Abiotrophia defectiva</citetitle></emphasis> comb. nov., respectively. <emphasis><citetitle>Int J Syst Bacteriol</citetitle></emphasis> <emphasis role="strong">45:</emphasis>798–803.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0010" role="bibliographyEntry">
            <para>10.<emphasis role="strong">Roggenkamp A, Abele-Horn M, Trebesius KH, Tretter U, Autenrieth IB, Heesemann J.</emphasis> 1998. <emphasis><citetitle>Abiotrophia elegans</citetitle></emphasis> sp. nov., a possible pathogen in patients with culture-negative endocarditis. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">36:</emphasis>100–104.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0011" role="bibliographyEntry">
            <para>11.<emphasis role="strong">Elliott JA, Facklam RR.</emphasis> 1993. Identification of Leuconostoc spp. by analysis of soluble whole-cell protein patterns. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">31:</emphasis>1030–1033.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0012" role="bibliographyEntry">
            <para>12.<emphasis role="strong">Collins MD, Samelis J, Metaxopoulos J, Wallbanks S.</emphasis> 1993. Taxonomic studies on some leuconostoc-like organisms from fermented sausages: description of a new genus <emphasis><citetitle>Weissella</citetitle></emphasis> for the <emphasis><citetitle>Leuconostoc paramesenteroides</citetitle></emphasis> group of species. <emphasis><citetitle>J Appl Bacteriol</citetitle></emphasis> <emphasis role="strong">75:</emphasis>595–603.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0013" role="bibliographyEntry">
            <para>13.<emphasis role="strong">Fusco V, Quero GM, Cho GS, Kabisch J, Meske D, Neve H, Bockelmann W, Franz CMAP.</emphasis> 2015. The genus <emphasis><citetitle>Weissella</citetitle></emphasis>: taxonomy, ecology and biotechnological potential. <emphasis><citetitle>Front Microbiol</citetitle></emphasis> <emphasis role="strong">6:</emphasis>155.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0014" role="bibliographyEntry">
            <para>14.<emphasis role="strong">Barros RR, Carvalho MG, Peralta JM, Facklam RR, Teixeira LM.</emphasis> 2001. Phenotypic and genotypic characterization of <emphasis><citetitle>Pediococcus</citetitle></emphasis> strains isolated from human clinical sources. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">39:</emphasis>1241–1246.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0015" role="bibliographyEntry">
            <para>15.<emphasis role="strong">Collins MD, Williams AM, Wallbanks S.</emphasis> 1990. The phylogeny of <emphasis><citetitle>Aerococcus</citetitle></emphasis> and <emphasis><citetitle>Pediococcus</citetitle></emphasis> as determined by 16S rRNA sequence analysis: description of <emphasis><citetitle>Tetragenococcus</citetitle></emphasis> gen. nov. <emphasis><citetitle>FEMS Microbiol Lett</citetitle></emphasis> <emphasis role="strong">58:</emphasis>255–262.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0016" role="bibliographyEntry">
            <para>16.<emphasis role="strong">Ennahar S, Cai Y.</emphasis> 2005. Biochemical and genetic evidence for the transfer of <emphasis><citetitle>Enterococcus solitarius</citetitle></emphasis> Collins et al. 1989 to the genus <emphasis><citetitle>Tetragenococcus</citetitle></emphasis> as <emphasis><citetitle>Tetragenococcus solitarius</citetitle></emphasis> comb. nov. <emphasis><citetitle>Int J Syst Evol Microbiol</citetitle></emphasis> <emphasis role="strong">55:</emphasis>589–592.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0017" role="bibliographyEntry">
            <para>17.<emphasis role="strong">Tunnicliff R.</emphasis> 1917. The cultivation of a micrococcus from blood in pre-eruptive and eruptive stages of measles. <emphasis><citetitle>JAMA</citetitle></emphasis> <emphasis role="strong">68:</emphasis>1028–1030.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0018" role="bibliographyEntry">
            <para>18.<emphasis role="strong">Kilpper-Bälz R, Schleifer KH.</emphasis> 1988. Transfer of <emphasis><citetitle>Streptococcus morbillorum</citetitle></emphasis> to the genus <emphasis><citetitle>Gemella</citetitle></emphasis> as <emphasis><citetitle>Gemella morbillorum</citetitle></emphasis> comb. nov. <emphasis><citetitle>Int J Syst Bacteriol</citetitle></emphasis> <emphasis role="strong">38:</emphasis>442–443.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0019" role="bibliographyEntry">
            <para>19.<emphasis role="strong">Collins MD, Hutson RA, Falsen E, Sjöden B, Facklam RR.</emphasis> 1998. <emphasis><citetitle>Gemella bergeriae</citetitle></emphasis> sp. nov., isolated from human clinical specimens. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">36:</emphasis>1290–1293.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0020" role="bibliographyEntry">
            <para>20.<emphasis role="strong">Collins MD, Hutson RA, Falsen E, Sjöden B, Facklam RR.</emphasis> 1998. Description of <emphasis><citetitle>Gemella sanguinis</citetitle></emphasis> sp. nov., isolated from human clinical specimens. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">36:</emphasis>3090–3093.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0021" role="bibliographyEntry">
            <para>21.<emphasis role="strong">Ulger-Toprak N, Summanen PH, Liu C, Rowlinson M-C, Finegold SM.</emphasis> 2010. <emphasis><citetitle>Gemella asaccharolytica</citetitle></emphasis> sp. nov., isolated from human clinical specimens. <emphasis><citetitle>Int J Syst Evol Microbiol</citetitle></emphasis> <emphasis role="strong">60:</emphasis>1023–1026.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0022" role="bibliographyEntry">
            <para>22.<emphasis role="strong">Hung W-C, Chen H-J, Tsai J-C, Tseng S-P, Lee T-F, Hsueh P-R, Shieh WY, Teng L-J.</emphasis> 2014. <emphasis><citetitle>Gemella parahaemolysans</citetitle></emphasis> sp. nov. and <emphasis><citetitle>Gemella taiwanensis</citetitle></emphasis> sp. nov., isolated from human clinical specimens. <emphasis><citetitle>Int J Syst Evol Microbiol</citetitle></emphasis> <emphasis role="strong">64:</emphasis>2060–2065.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0023" role="bibliographyEntry">
            <para>23.<emphasis role="strong">Aguirre M, Morrison D, Cookson BD, Gay FW, Collins MD.</emphasis> 1993. Phenotypic and phylogenetic characterization of some <emphasis><citetitle>Gemella</citetitle></emphasis>-like organisms from human infections: description of <emphasis><citetitle>Dolosigranulum pigrum</citetitle></emphasis> gen. nov., sp. nov. <emphasis><citetitle>J Appl Bacteriol</citetitle></emphasis> <emphasis role="strong">75:</emphasis>608–612.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0024" role="bibliographyEntry">
            <para>24.<emphasis role="strong">Laclaire L, Facklam R.</emphasis> 2000. Antimicrobial susceptibility and clinical sources of <emphasis><citetitle>Dolosigranulum pigrum</citetitle></emphasis> cultures. <emphasis><citetitle>Antimicrob Agents Chemother</citetitle></emphasis> <emphasis role="strong">44:</emphasis>2001–2003.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0025" role="bibliographyEntry">
            <para>25.<emphasis role="strong">Aguirre M, Collins MD.</emphasis> 1992. Phylogenetic analysis of some <emphasis><citetitle>Aerococcus</citetitle></emphasis>-like organisms from urinary tract infections: description of <emphasis><citetitle>Aerococcus urinae</citetitle></emphasis> sp. nov. <emphasis><citetitle>J Gen Microbiol</citetitle></emphasis> <emphasis role="strong">138:</emphasis>401–405.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0026" role="bibliographyEntry">
            <para>26.<emphasis role="strong">Christensen JJ, Whitney AM, Teixeira LM, Steigerwalt AG, Facklam RR, Korner B, Brenner DJ.</emphasis> 1997. <emphasis><citetitle>Aerococcus urinae</citetitle></emphasis>: intraspecies genetic and phenotypic relatedness. <emphasis><citetitle>Int J Syst Bacteriol</citetitle></emphasis> <emphasis role="strong">47:</emphasis>28–32.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0027" role="bibliographyEntry">
            <para>27.<emphasis role="strong">Collins MD, Jovita MR, Hutson RA, Ohlén M, Falsen E.</emphasis> 1999. <emphasis><citetitle>Aerococcus christensenii</citetitle></emphasis> sp. nov., from the human vagina. <emphasis><citetitle>Int J Syst Bacteriol</citetitle></emphasis> <emphasis role="strong">49:</emphasis>1125–1128.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0028" role="bibliographyEntry">
            <para>28.<emphasis role="strong">Facklam R, Lovgren M, Shewmaker PL, Tyrrell G.</emphasis> 2003. Phenotypic description and antimicrobial susceptibilities of <emphasis><citetitle>Aerococcus sanguinicola</citetitle></emphasis> isolates from human clinical samples. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">41:</emphasis>2587–2592.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0029" role="bibliographyEntry">
            <para>29.<emphasis role="strong">Lawson PA, Truberg-Jensen K, Collins MD.</emphasis> 2001. <emphasis><citetitle>Aerococcus sanguicola</citetitle></emphasis> sp. nov., isolated from a human clinical source. <emphasis><citetitle>Int J Syst Evol Microbiol</citetitle></emphasis> <emphasis role="strong">51:</emphasis>475–479.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0030" role="bibliographyEntry">
            <para>30.<emphasis role="strong">Lawson PA, Falsen E, Ohlén M, Collins MD.</emphasis> 2001. <emphasis><citetitle>Aerococcus urinaehominis</citetitle></emphasis> sp. nov., isolated from human urine. <emphasis><citetitle>Int J Syst Evol Microbiol</citetitle></emphasis> <emphasis role="strong">51:</emphasis>683–686.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0031" role="bibliographyEntry">
            <para>31.<emphasis role="strong">Carkaci D, Dargis R, Nielsen XC, Skovgaard O, Fuursted K, Christensen JJ.</emphasis> 2016. Complete genome sequences of <emphasis><citetitle>Aerococcus christensenii</citetitle></emphasis> CCUG 28831T, <emphasis><citetitle>Aerococcus sanguinicola</citetitle></emphasis> CCUG 43001T, <emphasis><citetitle>Aerococcus urinae</citetitle></emphasis> CCUG 36881T, <emphasis><citetitle>Aerococcus urinaeequi</citetitle></emphasis> CCUG 28094T, <emphasis><citetitle>Aerococcus urinaehominis</citetitle></emphasis> CCUG 42038 BT, and <emphasis><citetitle>Aerococcus viridans</citetitle></emphasis> CCUG 4311T. <emphasis><citetitle>Genome Announc</citetitle></emphasis> <emphasis role="strong">4:</emphasis>e00302-16.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0032" role="bibliographyEntry">
            <para>32.<emphasis role="strong">Collins MD, Aguirre M, Facklam RR, Shallcross J, Williams AM.</emphasis> 1992. <emphasis><citetitle>Globicatella sanguis</citetitle></emphasis> gen.nov., sp. nov., a new gram-positive catalase-negative bacterium from human sources. <emphasis><citetitle>J Appl Bacteriol</citetitle></emphasis> <emphasis role="strong">73:</emphasis>433–437.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0033" role="bibliographyEntry">
            <anchor id="ch0040s0018s0007a0003"/>
            <para>33.<emphasis role="strong">Collins MD, Falsen E, Lemozy J, Akervall E, Sjödén B, Lawson PA.</emphasis> 1997. Phenotypic and phylogenetic characterization of some <emphasis><citetitle>Globicatella</citetitle></emphasis>-like organisms from human sources: description of <emphasis><citetitle>Facklamia hominis</citetitle></emphasis> gen. nov., sp. nov. <emphasis><citetitle>Int J Syst Bacteriol</citetitle></emphasis> <emphasis role="strong">47:</emphasis>880–882.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0034" role="bibliographyEntry">
            <para>34.<emphasis role="strong">Collins MD, Hutson RA, Falsen E, Sjödén B.</emphasis> 1999. <emphasis><citetitle>Facklamia sourekii</citetitle></emphasis> sp. nov., isolated from human sources. <emphasis><citetitle>Int J Syst Bacteriol</citetitle></emphasis> <emphasis role="strong">49:</emphasis>635–638.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0035" role="bibliographyEntry">
            <para>35.<emphasis role="strong">Collins MD, Lawson PA, Monasterio R, Falsen E, Sjöden B, Facklam RR.</emphasis> 1998. <emphasis><citetitle>Facklamia ignava</citetitle></emphasis> sp. nov., isolated from human clinical specimens. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">36:</emphasis>2146–2148.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0036" role="bibliographyEntry">
            <para>36.<emphasis role="strong">Lawson PA, Collins MD, Falsen E, Sjöden B, Facklam RR.</emphasis> 1999. <emphasis><citetitle>Facklamia languida</citetitle></emphasis> sp. nov., isolated from human clinical specimens. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">37:</emphasis>1161–1164.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0037" role="bibliographyEntry">
            <para>37.<emphasis role="strong">Collins MD, Lawson PA, Monasterio R, Falsen E, Sjödén B, Facklam RR.</emphasis> 1999. <emphasis><citetitle>Ignavigranum ruoffiae</citetitle></emphasis> sp. nov., isolated from human clinical specimens. <emphasis><citetitle>Int J Syst Bacteriol</citetitle></emphasis> <emphasis role="strong">49:</emphasis>97–101.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0038" role="bibliographyEntry">
            <para>38.<emphasis role="strong">Collins MD, Rodriguez Jovita M, Hutson RA, Falsen E, Sjödén B, Facklam RR.</emphasis> 1999. <emphasis><citetitle>Dolosicoccus paucivorans</citetitle></emphasis> gen. nov., sp. nov., isolated from human blood. <emphasis><citetitle>Int J Syst Bacteriol</citetitle></emphasis> <emphasis role="strong">49:</emphasis>1439–1442.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0039" role="bibliographyEntry">
            <para>39.<emphasis role="strong">Collins MD, Facklam RR, Rodrigues UM, Ruoff KL.</emphasis> 1993. Phylogenetic analysis of some <emphasis><citetitle>Aerococcus-</citetitle></emphasis>like organisms from clinical sources: description of <emphasis><citetitle>Helcococcus kunzii</citetitle></emphasis> gen. nov., sp. nov. <emphasis><citetitle>Int J Syst Bacteriol</citetitle></emphasis> <emphasis role="strong">43:</emphasis>425–429.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0040" role="bibliographyEntry">
            <para>40.<emphasis role="strong">Collins MD, Falsen E, Brownlee K, Lawson PA.</emphasis> 2004. <emphasis><citetitle>Helcococcus sueciensis</citetitle></emphasis> sp. nov., isolated from a human wound. <emphasis><citetitle>Int J Syst Evol Microbiol</citetitle></emphasis> <emphasis role="strong">54:</emphasis>1557–1560.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0041" role="bibliographyEntry">
            <para>41.<emphasis role="strong">Kutzer P, Schulze C, Engelhardt A, Wieler LH, Nordhoff M.</emphasis> 2008. <emphasis><citetitle>Helcococcus ovis</citetitle></emphasis>, an emerging pathogen in bovine valvular endocarditis. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">46:</emphasis>3291–3295.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0042" role="bibliographyEntry">
            <para>42.<emphasis role="strong">Christensen JJ, Facklam RR.</emphasis> 2001. <emphasis><citetitle>Granulicatella</citetitle></emphasis> and <emphasis><citetitle>Abiotrophia</citetitle></emphasis> species from human clinical specimens. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">39:</emphasis>3520–3523.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0043" role="bibliographyEntry">
            <para>43.<emphasis role="strong">Reyn A.</emphasis> 1986. Genus <emphasis><citetitle>Gemella</citetitle></emphasis>, p 1081–1082. <emphasis><citetitle>In</citetitle></emphasis> Sneath PHA, Mair NS, Sharpe ME, Holt JG (ed), <emphasis><citetitle>Bergey’s Manual of Systematic Bacteriology</citetitle></emphasis>, vol 2. Williams &amp; Wilkins, Baltimore, MD.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0044" role="bibliographyEntry">
            <para>44.<emphasis role="strong">Al-Tawfiq JA, Kiwan G, Murrar H.</emphasis> 2007. <emphasis><citetitle>Granulicatella elegans</citetitle></emphasis> native valve infective endocarditis: case report and review. <emphasis><citetitle>Diagn Microbiol Infect Dis</citetitle></emphasis> <emphasis role="strong">57:</emphasis>439–441.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0045" role="bibliographyEntry">
            <para>45.<emphasis role="strong">Jeng A, Chen J, Katsivas T.</emphasis> 2005. Prosthetic valve endocarditis from <emphasis><citetitle>Granulicatella adiacens</citetitle></emphasis> (nutritionally variant streptococci). <emphasis><citetitle>J Infect</citetitle></emphasis> <emphasis role="strong">51:</emphasis>e125–e129.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0046" role="bibliographyEntry">
            <para>46.<emphasis role="strong">Namdari H, Kintner K, Jackson BA, Namdari S, Hughes JL, Peairs RR, Savage DJ.</emphasis> 1999. <emphasis><citetitle>Abiotrophia</citetitle></emphasis> species as a cause of endophthalmitis following cataract extraction. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">37:</emphasis>1564–1566.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0047" role="bibliographyEntry">
            <para>47.<emphasis role="strong">Cerceo E, Christie JD, Nachamkin I, Lautenbach E.</emphasis> 2004. Central nervous system infections due to <emphasis><citetitle>Abiotrophia</citetitle></emphasis> and <emphasis><citetitle>Granulicatella</citetitle></emphasis> species: an emerging challenge? <emphasis><citetitle>Diagn Microbiol Infect Dis</citetitle></emphasis> <emphasis role="strong">48:</emphasis>161–165.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0048" role="bibliographyEntry">
            <para>48.<emphasis role="strong">Altay M, Akay H, Yildiz E, Duranay M.</emphasis> 2008. A novel agent of peritoneal dialysis-related peritonitis: <emphasis><citetitle>Granulicatella adiacens</citetitle></emphasis>. <emphasis><citetitle>Perit Dial Int</citetitle></emphasis> <emphasis role="strong">28:</emphasis>96–97.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0049" role="bibliographyEntry">
            <para>49.<emphasis role="strong">Wilhelm N, Sire S, Le Coustumier A, Loubinoux J, Beljerd M, Bouvet A.</emphasis> 2005. First case of multiple discitis and sacroiliitis due to <emphasis><citetitle>Abiotrophia defectiva</citetitle></emphasis>. <emphasis><citetitle>Eur J Clin Microbiol Infect Dis</citetitle></emphasis> <emphasis role="strong">24:</emphasis>76–78.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0050" role="bibliographyEntry">
            <para>50.<emphasis role="strong">Taylor CE, Fang MA.</emphasis> 2006. Septic arthritis caused by <emphasis><citetitle>Abiotrophia defectiva</citetitle></emphasis>. <emphasis><citetitle>Arthritis Rheum</citetitle></emphasis> <emphasis role="strong">55:</emphasis>976–977.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0051" role="bibliographyEntry">
            <para>51.<emphasis role="strong">del Pozo JL, Garcia-Quetglas E, Hernaez S, Serrera A, Alonso M, Pina L, Leiva J, Azanza JR.</emphasis> 2008. <emphasis><citetitle>Granulicatella adiacens</citetitle></emphasis> breast implant-associated infection. <emphasis><citetitle>Diagn Microbiol Infect Dis</citetitle></emphasis> <emphasis role="strong">61:</emphasis>58–60.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0052" role="bibliographyEntry">
            <para>52.<emphasis role="strong">Cattoir V, Kobal A, Legrand P.</emphasis> 2010. <emphasis><citetitle>Aerococcus urinae</citetitle></emphasis> and <emphasis><citetitle>Aerococcus sanguinicola</citetitle></emphasis>, two frequently misidentified uropathogens. <emphasis><citetitle>Scand J Infect Dis</citetitle></emphasis> <emphasis role="strong">42:</emphasis>775–780.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0053" role="bibliographyEntry">
            <para>53.<emphasis role="strong">Nasoodi A, Ali AG, Gray WJ, Hedderwick SA.</emphasis> 2008. Spondylodiscitis due to <emphasis><citetitle>Aerococcus viridans</citetitle></emphasis>. <emphasis><citetitle>J Med Microbiol</citetitle></emphasis> <emphasis role="strong">57:</emphasis>532–533.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0054" role="bibliographyEntry">
            <para>54.<emphasis role="strong">Rasmussen M.</emphasis> 2016. <emphasis><citetitle>Aerococcus</citetitle></emphasis>: an increasingly acknowledged human pathogen. <emphasis><citetitle>Clin Microbiol Infect</citetitle></emphasis> <emphasis role="strong">22:</emphasis>22–27.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0055" role="bibliographyEntry">
            <para>55.<emphasis role="strong">Sunnerhagen T, Nilson B, Olaison L, Rasmussen M.</emphasis> 2016. Clinical and microbiological features of infective endocarditis caused by aerococci. <emphasis><citetitle>Infection</citetitle></emphasis> <emphasis role="strong">44:</emphasis>167–173.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0056" role="bibliographyEntry">
            <para>56.<emphasis role="strong">Santos R, Santos E, Gonçalves S, Marques A, Sequeira J, Abecasis P, Cadete M.</emphasis> 2003. Lymphadenitis caused by <emphasis><citetitle>Aerococcus urinae</citetitle></emphasis> infection. <emphasis><citetitle>Scand J Infect Dis</citetitle></emphasis> <emphasis role="strong">35:</emphasis>353–354.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0057" role="bibliographyEntry">
            <para>57.<emphasis role="strong">Colakoglu S, Turunc T, Taskoparan M, Aliskan H, Kizilkilic E, Demiroglu YZ, Arslan H.</emphasis> 2008. Three cases of serious infection caused by <emphasis><citetitle>Aerococcus urinae</citetitle></emphasis>: a patient with spontaneous bacterial peritonitis and two patients with bacteremia. <emphasis><citetitle>Infection</citetitle></emphasis> <emphasis role="strong">36:</emphasis>288–290.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0058" role="bibliographyEntry">
            <para>58.<emphasis role="strong">Carkaci D, Højholt K, Nielsen XC, Dargis R, Rasmussen S, Skovgaard O, Fuursted K, Andersen PS, Stegger M, Christensen JJ.</emphasis> 2017. Genomic characterization, phylogenetic analysis, and identification of virulence factors in <emphasis><citetitle>Aerococcus sanguinicola</citetitle></emphasis> and <emphasis><citetitle>Aerococcus urinae</citetitle></emphasis> strains isolated from infection episodes. <emphasis><citetitle>Microb Pathog</citetitle></emphasis> <emphasis role="strong">112:</emphasis>327–340.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0059" role="bibliographyEntry">
            <para>59.<emphasis role="strong">Facklam R.</emphasis> 2002. What happened to the streptococci: overview of taxonomic and nomenclature changes. <emphasis><citetitle>Clin Microbiol Rev</citetitle></emphasis> <emphasis role="strong">15:</emphasis>613–630.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0060" role="bibliographyEntry">
            <para>60.<emphasis role="strong">Hall GS, Gordon S, Schroeder S, Smith K, Anthony K, Procop GW.</emphasis> 2001. Case of synovitis potentially caused by <emphasis><citetitle>Dolosigranulum pigrum</citetitle></emphasis>. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">39:</emphasis>1202–1203.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0061" role="bibliographyEntry">
            <para>61.<emphasis role="strong">Lin J-C, Hou S-J, Huang L-U, Sun J-R, Chang W-K, Lu J-J.</emphasis> 2006. Acute cholecystitis accompanied by acute pancreatitis potentially caused by <emphasis><citetitle>Dolosigranulum pigrum</citetitle></emphasis>. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">44:</emphasis>2298–2299.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0062" role="bibliographyEntry">
            <para>62.<emphasis role="strong">Johnsen BO, Rønning EJ, Onken A, Figved W, Jenum PA.</emphasis> 2011. <emphasis><citetitle>Dolosigranulum pigrum</citetitle></emphasis> causing biomaterial-associated arthritis. <emphasis><citetitle>APMIS</citetitle></emphasis> <emphasis role="strong">119:</emphasis>85–87.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0063" role="bibliographyEntry">
            <para>63.<emphasis role="strong">Healy B, Beukenholt RW, Tuthill D, Ribeiro CD.</emphasis> 2005. <emphasis><citetitle>Facklamia hominis</citetitle></emphasis> causing chorioamnionitis and puerperal bacteraemia. <emphasis><citetitle>J Infect</citetitle></emphasis> <emphasis role="strong">50:</emphasis>353–355.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0064" role="bibliographyEntry">
            <para>64.<emphasis role="strong">Ananthakrishna R, Shankarappa RK, Jagadeesan N, Math RS, Karur S, Nanjappa MC.</emphasis> 2012. Infective endocarditis: a rare organism in an uncommon setting. <emphasis><citetitle>Case Rep Infect Dis</citetitle></emphasis> <emphasis role="strong">2012:</emphasis>307852.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0065" role="bibliographyEntry">
            <para>65.<emphasis role="strong">Khan R, Urban C, Rubin D, Segal-Maurer S.</emphasis> 2004. Subacute endocarditis caused by <emphasis><citetitle>Gemella haemolysans</citetitle></emphasis> and a review of the literature. <emphasis><citetitle>Scand J Infect Dis</citetitle></emphasis> <emphasis role="strong">36:</emphasis>885–888.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0066" role="bibliographyEntry">
            <para>66.<emphasis role="strong">Al-Hujailan G, Lagacé-Wiens P.</emphasis> 2007. Mechanical valve endocarditis caused by <emphasis><citetitle>Gemella morbillorum</citetitle></emphasis>. <emphasis><citetitle>J Med Microbiol</citetitle></emphasis> <emphasis role="strong">56:</emphasis>1689–1691.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0067" role="bibliographyEntry">
            <para>67.<emphasis role="strong">Vasishtha S, Isenberg HD, Sood SK.</emphasis> 1996. <emphasis><citetitle>Gemella morbillorum</citetitle></emphasis> as a cause of septic shock. <emphasis><citetitle>Clin Infect Dis</citetitle></emphasis> <emphasis role="strong">22:</emphasis>1084–1086.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0068" role="bibliographyEntry">
            <para>68.<emphasis role="strong">Lee MR, Lee S-O, Kim S-Y, Yang SM, Seo Y-H, Cho YK.</emphasis> 2004. Brain abscess due to <emphasis><citetitle>Gemella haemolysans</citetitle></emphasis>. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">42:</emphasis>2338–2340.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0069" role="bibliographyEntry">
            <para>69.<emphasis role="strong">Benedetti P, Rassu M, Branscombe M, Sefton A, Pellizzer G.</emphasis> 2009. <emphasis><citetitle>Gemella morbillorum</citetitle></emphasis>: an underestimated aetiology of central nervous system infection? <emphasis><citetitle>J Med Microbiol</citetitle></emphasis> <emphasis role="strong">58:</emphasis>1652–1656.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0070" role="bibliographyEntry">
            <para>70.<emphasis role="strong">Eggelmeijer F, Petit P, Dijkmans BA.</emphasis> 1992. Total knee arthroplasty infection due to <emphasis><citetitle>Gemella haemolysans</citetitle></emphasis>. <emphasis><citetitle>Br J Rheumatol</citetitle></emphasis> <emphasis role="strong">31:</emphasis>67–69.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0071" role="bibliographyEntry">
            <para>71.<emphasis role="strong">Roche M, Smyth E.</emphasis> 2005. A case of septic arthritis due to infection with <emphasis><citetitle>Gemella morbillorum</citetitle></emphasis>. <emphasis><citetitle>J Infect</citetitle></emphasis> <emphasis role="strong">51:</emphasis>e187–e189.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0072" role="bibliographyEntry">
            <para>72.<emphasis role="strong">Anil M, Ozkalay N, Helvaci M, Agus N, Guler O, Dikerler A, Kanar B.</emphasis> 2007. Meningitis due to <emphasis><citetitle>Gemella haemolysans</citetitle></emphasis> in a pediatric case. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">45:</emphasis>2337–2339.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0073" role="bibliographyEntry">
            <para>73.<emphasis role="strong">Ritterband D, Shah M, Kresloff M, Intal M, Shabto U, Seedor J.</emphasis> 2002. <emphasis><citetitle>Gemella haemolysans</citetitle></emphasis> keratitis and consecutive endophthalmitis. <emphasis><citetitle>Am J Ophthalmol</citetitle></emphasis> <emphasis role="strong">133:</emphasis>268–269.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0074" role="bibliographyEntry">
            <para>74.<emphasis role="strong">Kailasanathan A, Anderson DF.</emphasis> 2007. Infectious crystalline keratopathy caused by <emphasis><citetitle>Gemella haemolysans</citetitle></emphasis>. <emphasis><citetitle>Cornea</citetitle></emphasis> <emphasis role="strong">26:</emphasis>643–644.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0075" role="bibliographyEntry">
            <para>75.<emphasis role="strong">Valipour A, Koller H, Setinek U, Burghuber OC.</emphasis> 2005. Pleural empyema associated with <emphasis><citetitle>Gemella morbillorum</citetitle></emphasis>: report of a case and review of the literature. <emphasis><citetitle>Scand J Infect Dis</citetitle></emphasis> <emphasis role="strong">37:</emphasis>378–381.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0076" role="bibliographyEntry">
            <para>76.<emphasis role="strong">Lai C-C, Wu C-H, Chen J-T, Hsueh P-R.</emphasis> 2008. Peritoneal dialysis-related peritonitis caused by <emphasis><citetitle>Gemella morbillorum</citetitle></emphasis> in a patient with systemic lupus erythematosus receiving steroid therapy. <emphasis><citetitle>J Microbiol Immunol Infect</citetitle></emphasis> <emphasis role="strong">41:</emphasis>272–274.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0077" role="bibliographyEntry">
            <anchor id="ch0040s0018s0007a0004"/>
            <para>77.<emphasis role="strong">Logan LK, Zheng X, Shulman ST.</emphasis> 2008. <emphasis><citetitle>Gemella bergeriae</citetitle></emphasis> endocarditis in a boy. <emphasis><citetitle>Pediatr Infect Dis J</citetitle></emphasis> <emphasis role="strong">27:</emphasis>184–186.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0078" role="bibliographyEntry">
            <para>78.<emphasis role="strong">Leung DT, Davis EM, Qian Q, Gold HS.</emphasis> 2011. First report of prosthetic joint infection by <emphasis><citetitle>Gemella sanguinis</citetitle></emphasis> and associated “pseudosatelliting” phenomenon on culture. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">49:</emphasis>3395–3397.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0079" role="bibliographyEntry">
            <para>79.<emphasis role="strong">García López E, Martín-Galiano AJ.</emphasis> 2020. The versatility of opportunistic infections caused by <emphasis><citetitle>Gemella</citetitle></emphasis> isolates is supported by the carriage of virulence factors from multiple origins. <emphasis><citetitle>Front Microbiol</citetitle></emphasis> <emphasis role="strong">11:</emphasis>524.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0080" role="bibliographyEntry">
            <para>80.<emphasis role="strong">Seegmüller I, van der Linden M, Heeg C, Reinert RR.</emphasis> 2007. <emphasis><citetitle>Globicatella sanguinis</citetitle></emphasis> is an etiological agent of ventriculoperitoneal shunt-associated meningitis. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">45:</emphasis>666–667.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0081" role="bibliographyEntry">
            <para>81.<emphasis role="strong">Miller AO, Buckwalter SP, Henry MW, Wu F, Maloney KF, Abraham BK, Hartman BJ, Brause BD, Whittier S, Walsh TJ, Schuetz AN.</emphasis> 2017. <emphasis><citetitle>Globicatella sanguinis</citetitle></emphasis> Osteomyelitis and Bacteremia: Review of an Emerging Human Pathogen with an Expanding Spectrum of Disease. <emphasis><citetitle>Open Forum Infect Dis</citetitle></emphasis> 4<emphasis role="strong">:</emphasis>ofw277.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0082" role="bibliographyEntry">
            <para>82.<emphasis role="strong">Vergne A, Guérin F, Lienhard R, Le Coustumier A, Daurel C, Isnard C, Marty N, Poyart C, Cattoir V.</emphasis> 2015. Identification and clinical significance of <emphasis><citetitle>Helcococcus kunzii</citetitle></emphasis> in human samples. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">53:</emphasis>2703–2705.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0083" role="bibliographyEntry">
            <para>83.<emphasis role="strong">Elliott JA, Collins MD, Pigott NE, Facklam RR.</emphasis> 1991. Differentiation of <emphasis><citetitle>Lactococcus lactis</citetitle></emphasis> and <emphasis><citetitle>Lactococcus garvieae</citetitle></emphasis> from humans by comparison of whole-cell protein patterns. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">29:</emphasis>2731–2734.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0084" role="bibliographyEntry">
            <para>84.<emphasis role="strong">Chan JFW, Woo PCY, Teng JLL, Lau SKP, Leung SSM, Tam FCC, Yuen K-Y.</emphasis> 2011. Primary infective spondylodiscitis caused by <emphasis><citetitle>Lactococcus garvieae</citetitle></emphasis> and a review of human <emphasis><citetitle>L. garvieae</citetitle></emphasis> infections. <emphasis><citetitle>Infection</citetitle></emphasis> <emphasis role="strong">39:</emphasis>259–264.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0085" role="bibliographyEntry">
            <para>85.<emphasis role="strong">Guz G, Colak B, Hizel K, Suyani E, Sindel S.</emphasis> 2006. Peritonitis due to <emphasis><citetitle>Lactococcus lactis</citetitle></emphasis> in a CAPD patient. <emphasis><citetitle>Scand J Infect Dis</citetitle></emphasis> <emphasis role="strong">38:</emphasis>698–699.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0086" role="bibliographyEntry">
            <para>86.<emphasis role="strong">Antolín J, Cigüenza R, Salueña I, Vázquez E, Hernández J, Espinós D.</emphasis> 2004. Liver abscess caused by <emphasis><citetitle>Lactococcus lactis</citetitle></emphasis> cremoris: a new pathogen. <emphasis><citetitle>Scand J Infect Dis</citetitle></emphasis> <emphasis role="strong">36:</emphasis>490–491.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0087" role="bibliographyEntry">
            <para>87.<emphasis role="strong">Kim JH, Go J, Cho CR, Kim JI, Lee MS, Park SC.</emphasis> 2013. First report of human acute acalculous cholecystitis caused by the fish pathogen <emphasis><citetitle>Lactococcus garvieae</citetitle></emphasis>. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">51:</emphasis>712–714.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0088" role="bibliographyEntry">
            <para>88.<emphasis role="strong">Aubin GG, Bémer P, Guillouzouic A, Crémet L, Touchais S, Fraquet N, Boutoille D, Reynaud A, Lepelletier D, Corvec S.</emphasis> 2011. First report of a hip prosthetic and joint infection caused by <emphasis><citetitle>Lactococcus garvieae</citetitle></emphasis> in a woman fishmonger. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">49:</emphasis>2074–2076.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0089" role="bibliographyEntry">
            <para>89.<emphasis role="strong">Handwerger S, Horowitz H, Coburn K, Kolokathis A, Wormser GP.</emphasis> 1990. Infection due to <emphasis><citetitle>Leuconostoc</citetitle></emphasis> species: six cases and review. <emphasis><citetitle>Rev Infect Dis</citetitle></emphasis> <emphasis role="strong">12:</emphasis>602–610.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0090" role="bibliographyEntry">
            <para>90.<emphasis role="strong">Zaoui A, Brousse C, Bletry O, Augouard LW, Boisaubert B.</emphasis> 2005. <emphasis><citetitle>Leuconostoc</citetitle></emphasis> osteomyelitis. <emphasis><citetitle>Joint Bone Spine</citetitle></emphasis> <emphasis role="strong">72:</emphasis>79–81.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0091" role="bibliographyEntry">
            <para>91.<emphasis role="strong">Deye G, Lewis J, Patterson J, Jorgensen J.</emphasis> 2003. A case of <emphasis><citetitle>Leuconostoc ventriculitis</citetitle></emphasis> with resistance to carbapenem antibiotics. <emphasis><citetitle>Clin Infect Dis</citetitle></emphasis> <emphasis role="strong">37:</emphasis>869–870.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0092" role="bibliographyEntry">
            <para>92.<emphasis role="strong">Albanese A, Spanu T, Sali M, Novegno F, D’Inzeo T, Santangelo R, Mangiola A, Anile C, Fadda G.</emphasis> 2006. Molecular identification of <emphasis><citetitle>Leuconostoc mesenteroides</citetitle></emphasis> as a cause of brain abscess in an immunocompromised patient. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">44:</emphasis>3044–3045.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0093" role="bibliographyEntry">
            <para>93.<emphasis role="strong">Kumudhan D, Mars S.</emphasis> 2004. <emphasis><citetitle>Leuconostoc mesenteroides</citetitle></emphasis> as a cause of post-operative endophthalmitis—a case report. <emphasis><citetitle>Eye (Lond)</citetitle></emphasis> <emphasis role="strong">18:</emphasis>1023–1024.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0094" role="bibliographyEntry">
            <para>94.<emphasis role="strong">Mayeur C, Gratadoux J-J, Bridonneau C, Chegdani F, Larroque B, Kapel N, Corcos O, Thomas M, Joly F.</emphasis> 2013. Faecal D/L lactate ratio is a metabolic signature of microbiota imbalance in patients with short bowel syndrome. <emphasis><citetitle>PLoS One</citetitle></emphasis> <emphasis role="strong">8:</emphasis>e54335.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0095" role="bibliographyEntry">
            <para>95.<emphasis role="strong">Florescu D, Hill L, Sudan D, Iwen PC.</emphasis> 2008. <emphasis><citetitle>Leuconostoc</citetitle></emphasis> bacteremia in pediatric patients with short bowel syndrome: case series and review. <emphasis><citetitle>Pediatr Infect Dis J</citetitle></emphasis> <emphasis role="strong">27:</emphasis>1013–1019.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0096" role="bibliographyEntry">
            <para>96.<emphasis role="strong">Mastro TD, Spika JS, Lozano P, Appel J, Facklam RR.</emphasis> 1990. Vancomycin-resistant <emphasis><citetitle>Pediococcus acidilactici</citetitle></emphasis>: nine cases of bacteremia. <emphasis><citetitle>J Infect Dis</citetitle></emphasis> <emphasis role="strong">161:</emphasis>956–960.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0097" role="bibliographyEntry">
            <para>97.<emphasis role="strong">Sire JM, Donnio PY, Mesnard R, Pouëdras P, Avril JL.</emphasis> 1992. Septicemia and hepatic abscess caused by <emphasis><citetitle>Pediococcus acidilactici</citetitle></emphasis>. <emphasis><citetitle>Eur J Clin Microbiol Infect Dis</citetitle></emphasis> <emphasis role="strong">11:</emphasis>623–625.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0098" role="bibliographyEntry">
            <para>98.<emphasis role="strong">Barton LL, Rider ED, Coen RW.</emphasis> 2001. Bacteremic infection with <emphasis><citetitle>Pediococcus</citetitle></emphasis>: vancomycin-resistant opportunist. <emphasis><citetitle>Pediatrics</citetitle></emphasis> <emphasis role="strong">107:</emphasis>775–776.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0099" role="bibliographyEntry">
            <para>99.<emphasis role="strong">Teixeira LM, Carvalho MG, Merquior VL, Steigerwalt AG, Brenner DJ, Facklam RR.</emphasis> 1997. Phenotypic and genotypic characterization of <emphasis><citetitle>Vagococcus fluvialis</citetitle></emphasis>, including strains isolated from human sources. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">35:</emphasis>2778–2781.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0100" role="bibliographyEntry">
            <para>100.<emphasis role="strong">Al-Ahmad A, Pelz K, Schirrmeister JF, Hellwig E, Pukall R.</emphasis> 2008. Characterization of the first oral <emphasis><citetitle>vagococcus</citetitle></emphasis> isolate from a root-filled tooth with periradicular lesions. <emphasis><citetitle>Curr Microbiol</citetitle></emphasis> <emphasis role="strong">57:</emphasis>235–238.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0101" role="bibliographyEntry">
            <para>101.<emphasis role="strong">Altintas I, Andrews V, Larsen MV.</emphasis> 2020. First reported human bloodstream infection with <emphasis><citetitle>Vagococcus lutrae</citetitle></emphasis>. <emphasis><citetitle>New Microbes New Infect</citetitle></emphasis> <emphasis role="strong">34:</emphasis>100649.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0102" role="bibliographyEntry">
            <para>102.<emphasis role="strong">Garcia V, Abat C, Rolain JM.</emphasis> 2015. Report of the first <emphasis><citetitle>Vagococcus lutrae</citetitle></emphasis> human infection, Marseille, France. <emphasis><citetitle>New Microbes New Infect</citetitle></emphasis> <emphasis role="strong">9:</emphasis>56–57.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0103" role="bibliographyEntry">
            <para>103.<emphasis role="strong">Kamboj K, Vasquez A, Balada-Llasat JM.</emphasis> 2015. Identification and significance of <emphasis><citetitle>Weissella</citetitle></emphasis> species infections. <emphasis><citetitle>Front Microbiol</citetitle></emphasis> <emphasis role="strong">6:</emphasis>1204.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0104" role="bibliographyEntry">
            <para>104.<emphasis role="strong">Cheaito RA, Awar G, Alkozah M, Cheaito MA, El Majzoub I.</emphasis> 2020. Meningitis due to <emphasis><citetitle>Weissella confusa</citetitle></emphasis>. <emphasis><citetitle>Am J Emerg Med</citetitle></emphasis> <emphasis role="strong">38:</emphasis>1298.e1–1298.e3.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0105" role="bibliographyEntry">
            <para>105.<emphasis role="strong">Fiori B, D’Inzeo T, Giaquinto A, Menchinelli G, Liotti FM, de Maio F, De Angelis G, Quaranta G, Nagel D, Tumbarello M, Posteraro B, Sanguinetti M, Spanu T.</emphasis> 2016. Optimized use of the MALDI BioTyper system and the FilmArray BCID panel for direct identification of microbial pathogens from positive blood cultures. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">54:</emphasis>576–584.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0106" role="bibliographyEntry">
            <para>106.<emphasis role="strong">Melendez DP, Greenwood-Quaintance KE, Berbari EF, Osmon DR, Mandrekar JN, Hanssen AD, Patel R.</emphasis> 2016. Evaluation of a genus- and group-specific rapid PCR assay panel on synovial fluid for diagnosis of prosthetic knee infection. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">54:</emphasis>120–126.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0107" role="bibliographyEntry">
            <para>107.<emphasis role="strong">Jensen KH, Dargis R, Christensen JJ, Kemp M.</emphasis> 2014. Ribosomal PCR and DNA sequencing for detection and identification of bacteria: experience from 6 years of routine analyses of patient samples. <emphasis><citetitle>APMIS</citetitle></emphasis> <emphasis role="strong">122:</emphasis>248–255.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0108" role="bibliographyEntry">
            <para>108.<emphasis role="strong">Ruoff KL, Kuritzkes DR, Wolfson JS, Ferraro MJ.</emphasis> 1988. Vancomycin-resistant gram-positive bacteria isolated from human sources. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">26:</emphasis>2064–2068.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0109" role="bibliographyEntry">
            <para>109.<emphasis role="strong">Beighton D, Homer KA, Bouvet A, Storey AR.</emphasis> 1995. Analysis of enzymatic activities for differentiation of two species of nutritionally variant streptococci, <emphasis><citetitle>Streptococcus defectivus</citetitle></emphasis> and <emphasis><citetitle>Streptococcus adjacens</citetitle></emphasis>. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">33:</emphasis>1584–1587.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0110" role="bibliographyEntry">
            <para>110.<emphasis role="strong">Bouvet A, Villeroy F, Cheng F, Lamesch C, Williamson R, Gutmann L.</emphasis> 1985. Characterization of nutritionally variant streptococci by biochemical tests and penicillin-binding proteins. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">22:</emphasis>1030–1034.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0111" role="bibliographyEntry">
            <para>111.<emphasis role="strong">Evans JB.</emphasis> 1986. Genus <emphasis><citetitle>Aerococcus</citetitle></emphasis>, p 1080. <emphasis><citetitle>In</citetitle></emphasis> Sneath PHA, Mair NS, Sharpe ME, Holt JG (ed), <emphasis><citetitle>Bergey’s Manual of Systematic Bacteriology</citetitle></emphasis>, vol 2. Williams &amp; Wilkins, Baltimore, MD.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0112" role="bibliographyEntry">
            <para>112.<emphasis role="strong">Christensen JJ, Vibits H, Ursing J, Korner B.</emphasis> 1991. <emphasis><citetitle>Aerococcus</citetitle></emphasis>-like organism, a newly recognized potential urinary tract pathogen. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">29:</emphasis>1049–1053.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0113" role="bibliographyEntry">
            <para>113.<emphasis role="strong">Facklam RR, Washington JA II.</emphasis> 1991. <emphasis><citetitle>Streptococcus</citetitle></emphasis> and related catalase-negative Gram-positive cocci, p 238–257. <emphasis><citetitle>In</citetitle></emphasis> Balows A, Hausler WJ Jr, Herrmann KL, Isenb HD, Shadomy HJ (ed), <emphasis><citetitle>Manual of Clinical Microbiology</citetitle></emphasis>, 5th ed. American Society for Microbiology, Washington, DC.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0114" role="bibliographyEntry">
            <para>114.<emphasis role="strong">LaClaire LL, Facklam RR.</emphasis> 2000. Comparison of three commercial rapid identification systems for the unusual gram-positive cocci <emphasis><citetitle>Dolosigranulum pigrum</citetitle>, <citetitle>Ignavigranum ruoffiae</citetitle></emphasis>, and <emphasis><citetitle>Facklamia</citetitle></emphasis> species. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">38:</emphasis>2037–2042.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0115" role="bibliographyEntry">
            <para>115.<emphasis role="strong">Elliott JA, Facklam RR.</emphasis> 1996. Antimicrobial susceptibilities of <emphasis><citetitle>Lactococcus lactis</citetitle></emphasis> and <emphasis><citetitle>Lactococcus garvieae</citetitle></emphasis> and a proposed method to discriminate between them. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">34:</emphasis>1296–1298.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0116" role="bibliographyEntry">
            <anchor id="ch0040s0018s0007a0005"/>
            <para>116.<emphasis role="strong">Bosshard PP, Abels S, Altwegg M, Böttger EC, Zbinden R.</emphasis> 2004. Comparison of conventional and molecular methods for identification of aerobic catalase-negative gram-positive cocci in the clinical laboratory. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">42:</emphasis>2065–2073.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0117" role="bibliographyEntry">
            <para>117.<emphasis role="strong">Wallet F, Loïez C, Renaux E, Lemaitre N, Courcol RJ.</emphasis> 2005. Performances of VITEK 2 colorimetric cards for identification of gram-positive and gram-negative bacteria. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">43:</emphasis>4402–4406.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0118" role="bibliographyEntry">
            <para>118.<emphasis role="strong">Woo PCY, Ng KHL, Lau SKP, Yip KT, Fung AMY, Leung KW, Tam DMW, Que TL, Yuen KY.</emphasis> 2003. Usefulness of the MicroSeq 500 16S ribosomal DNA-based bacterial identification system for identification of clinically significant bacterial isolates with ambiguous biochemical profiles. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">41:</emphasis>1996–2001.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0119" role="bibliographyEntry">
            <para>119.<emphasis role="strong">Petti CA, Brandt ME, Church DL, Emler S, Simmon K, Zelazny AM.</emphasis> 2018. <emphasis><citetitle>CLSI MM 18, Interpretive Criteria for Identification of Bacteria and Fungi by Targeted DNA Sequencing</citetitle></emphasis>, 2nd ed. Clinical and Laboratory Standards Institute, Wayne, PA.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0120" role="bibliographyEntry">
            <para>120.<emphasis role="strong">Kolbert CP, Rys PN, Hopkins M, Lynch DT, Germer JJ, O’Sullivan CE, Trampuz A, Patel R.</emphasis> 2004. 16S ribosomal DNA sequence analysis for identification of bacteria in a clinical microbiological laboratory, p 361–379. <emphasis><citetitle>In</citetitle></emphasis> Persing DH, Tenover FC, Versalovic J, Tang YW, Unger ER, Relman DA, White TJ (ed), <emphasis><citetitle>Molecular Microbiology: Diagnostic Principles and Practice</citetitle></emphasis>. ASM Press, Washington, DC.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0121" role="bibliographyEntry">
            <para>121.<emphasis role="strong">Christensen JJ, Andresen K, Justesen T, Kemp M.</emphasis> 2005. Ribosomal DNA sequencing: experiences from use in the Danish National Reference Laboratory for identification of bacteria. <emphasis><citetitle>Acta Pathol Microbiol Scand Suppl</citetitle></emphasis> <emphasis role="strong">113:</emphasis>621–628.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0122" role="bibliographyEntry">
            <para>122.<emphasis role="strong">Ibler K, Truberg Jensen K, Ostergaard C, Sönksen UW, Bruun B, Schønheyder HC, Kemp M, Dargis R, Andresen K, Christensen JJ.</emphasis> 2008. Six cases of <emphasis><citetitle>Aerococcus sanguinicola</citetitle></emphasis> infection: clinical relevance and bacterial identification. <emphasis><citetitle>Scand J Infect Dis</citetitle></emphasis> <emphasis role="strong">40:</emphasis>761–765.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0123" role="bibliographyEntry">
            <para>123.<emphasis role="strong">Christensen JJ, Kilian M, Fussing V, Andresen K, Blom J, Korner B, Steigerwalt AG.</emphasis> 2005. <emphasis><citetitle>Aerococcus urinae</citetitle></emphasis>: polyphasic characterization of the species. <emphasis><citetitle>APMIS</citetitle></emphasis> <emphasis role="strong">113:</emphasis>517–525.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0124" role="bibliographyEntry">
            <para>124.<emphasis role="strong">Abdul-Redha RJ, Balslew U, Christensen JJ, Kemp M.</emphasis> 2007. <emphasis><citetitle>Globicatella sanguinis</citetitle></emphasis> bacteraemia identified by partial 16S rRNA gene sequencing. <emphasis><citetitle>Scand J Infect Dis</citetitle></emphasis> <emphasis role="strong">39:</emphasis>745–748.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0125" role="bibliographyEntry">
            <para>125.<emphasis role="strong">Abdul-Redha RJ, Prag J, Sonksen UW, Kemp M, Andresen K, Christensen JJ.</emphasis> 2007. <emphasis><citetitle>Granulicatella elegans</citetitle></emphasis> bacteraemia in patients with abdominal infections. <emphasis><citetitle>Scand J Infect Dis</citetitle></emphasis> <emphasis role="strong">39:</emphasis>830–833.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0126" role="bibliographyEntry">
            <para>126.<emphasis role="strong">Maiwald M.</emphasis> 2004. Broad-range PCR for detection and identification of bacteria, p 379–390. <emphasis><citetitle>In</citetitle></emphasis> Persing DH, Tenover FC, Versalovic J, Tang YW, Unger ER, Relman DA, White TJ (ed), <emphasis><citetitle>Molecular Microbiology: Diagnostic Principles and Practice</citetitle></emphasis>. ASM Press Washington, DC.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0127" role="bibliographyEntry">
            <para>127.<emphasis role="strong">Voldstedlund M, Nørum Pedersen L, Baandrup U, Klaaborg KE, Fuursted K.</emphasis> 2008. Broad-range PCR and sequencing in routine diagnosis of infective endocarditis. <emphasis><citetitle>APMIS</citetitle></emphasis> <emphasis role="strong">116:</emphasis>190–198.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0128" role="bibliographyEntry">
            <para>128.<emphasis role="strong">Kommedal Ø, Lekang K, Langeland N, Wiker HG.</emphasis> 2011. Characterization of polybacterial clinical samples using a set of group-specific broad-range primers targeting the 16S rRNA gene followed by DNA sequencing and RipSeq analysis. <emphasis><citetitle>J Med Microbiol</citetitle></emphasis> <emphasis role="strong">60:</emphasis>927–936.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0129" role="bibliographyEntry">
            <para>129.<emphasis role="strong">Kommedal Ø, Simmon K, Karaca D, Langeland N, Wiker HG.</emphasis> 2012. Dual priming oligonucleotides for broad-range amplification of the bacterial 16S rRNA gene directly from human clinical specimens. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">50:</emphasis>1289–1294.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0130" role="bibliographyEntry">
            <para>130.<emphasis role="strong">Drancourt M, Roux V, Fournier PE, Raoult D.</emphasis> 2004. <emphasis><citetitle>rpoB</citetitle></emphasis> gene sequence-based identification of aerobic Gram-positive cocci of the genera <emphasis><citetitle>Streptococcus</citetitle>, <citetitle>Enterococcus</citetitle>, <citetitle>Gemella</citetitle>, <citetitle>Abiotrophia</citetitle></emphasis>, and <emphasis><citetitle>Granulicatella</citetitle></emphasis>. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">42:</emphasis>497–504.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0131" role="bibliographyEntry">
            <para>131.<emphasis role="strong">Hung W-C, Tseng S-P, Chen H-J, Tsai J-C, Chang C-H, Lee T-F, Hsueh P-R, Teng L-J.</emphasis> 2010. Use of <emphasis><citetitle>groESL</citetitle></emphasis> as a target for identification of <emphasis><citetitle>Abiotrophia</citetitle>, <citetitle>Granulicatella</citetitle></emphasis>, and <emphasis><citetitle>Gemella</citetitle></emphasis> species. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">48:</emphasis>3532–3538.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0132" role="bibliographyEntry">
            <para>132.<emphasis role="strong">Tung SK, Teng LJ, Vaneechoutte M, Chen HM, Chang TC.</emphasis> 2007. Identification of species of <emphasis><citetitle>Abiotrophia</citetitle>, <citetitle>Enterococcus</citetitle>, <citetitle>Granulicatella</citetitle></emphasis> and <emphasis><citetitle>Streptococcus</citetitle></emphasis> by sequence analysis of the ribosomal 16S-23S intergenic spacer region. <emphasis><citetitle>J Med Microbiol</citetitle></emphasis> <emphasis role="strong">56:</emphasis>504–513.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0133" role="bibliographyEntry">
            <para>133.<emphasis role="strong">Tung SK, Teng LJ, Vaneechoutte M, Chen HM, Chang TC.</emphasis> 2006. Array-based identification of species of the genera <emphasis><citetitle>Abiotrophia</citetitle>, <citetitle>Enterococcus</citetitle>, <citetitle>Granulicatella</citetitle></emphasis>, and <emphasis><citetitle>Streptococcus</citetitle></emphasis>. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">44:</emphasis>4414–4424.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0134" role="bibliographyEntry">
            <para>134.<emphasis role="strong">Nielsen XC, Carkaci D, Dargis R, Hannecke LJ, Justesen US, Kemp M, Christensen JJ, Hammer M.</emphasis> 2013. 16S-23S intergenic spacer (ITS) region sequence analysis: applicability and usefulness in identifying genera and species resembling non-hemolytic streptococci. <emphasis><citetitle>Clin Microbiol</citetitle></emphasis> <emphasis role="strong">2:</emphasis>130.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0135" role="bibliographyEntry">
            <para>135.<emphasis role="strong">Christensen JJ, Dargis R, Hammer M, Justesen US, Nielsen XC, Kemp M, Danish MALDI-TOF MS Study Group.</emphasis> 2012. Matrix-assisted laser desorption ionization-time of flight mass spectrometry analysis of Gram-positive, catalase-negative cocci not belonging to the <emphasis><citetitle>Streptococcus</citetitle></emphasis> or <emphasis><citetitle>Enterococcus</citetitle></emphasis> genus and benefits of database extension. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">50:</emphasis>1787–1791.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0136" role="bibliographyEntry">
            <para>136.<emphasis role="strong">Rychert J, Burnham C-AD, Bythrow M, Garner OB, Ginocchio CC, Jennemann R, Lewinski MA, Manji R, Mochon AB, Procop GW, Richter SS, Sercia L, Westblade LF, Ferraro MJ, Branda JA.</emphasis> 2013. Multicenter evaluation of the Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry system for identification of Gram-positive aerobic bacteria. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">51:</emphasis>2225–2231.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0137" role="bibliographyEntry">
            <para>137.<emphasis role="strong">Senneby E, Nilson B, Petersson A-C, Rasmussen M.</emphasis> 2013. Matrix-assisted laser desorption ionization-time of flight mass spectrometry is a sensitive and specific method for identification of aerococci. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">51:</emphasis>1303–1304.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0138" role="bibliographyEntry">
            <para>138.<emphasis role="strong">Tanigawa K, Kawabata H, Watanabe K.</emphasis> 2010. Identification and typing of <emphasis><citetitle>Lactococcus lactis</citetitle></emphasis> by matrix-assisted laser desorption ionization-time of flight mass spectrometry. <emphasis><citetitle>Appl Environ Microbiol</citetitle></emphasis> <emphasis role="strong">76:</emphasis>4055–4062.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0139" role="bibliographyEntry">
            <para>139.<emphasis role="strong">De Bruyne K, Slabbinck B, Waegeman W, Vauterin P, De Baets B, Vandamme P.</emphasis> 2011. Bacterial species identification from MALDI-TOF mass spectra through data analysis and machine learning. <emphasis><citetitle>Syst Appl Microbiol</citetitle></emphasis> <emphasis role="strong">34:</emphasis>20–29.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0140" role="bibliographyEntry">
            <para>140.<emphasis role="strong">Albesharat R, Ehrmann MA, Korakli M, Yazaji S, Vogel RF.</emphasis> 2011. Phenotypic and genotypic analyses of lactic acid bacteria in local fermented food, breast milk and faeces of mothers and their babies. <emphasis><citetitle>Syst Appl Microbiol</citetitle></emphasis> <emphasis role="strong">34:</emphasis>148–155.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0141" role="bibliographyEntry">
            <para>141.<emphasis role="strong">Sharma A, Kaur J, Lee S, Park YS.</emphasis> 2018. Analysis of <emphasis><citetitle>Leuconostoc citreum</citetitle></emphasis> strains using multilocus sequence typing. <emphasis><citetitle>Food Sci Biotechnol</citetitle></emphasis> <emphasis role="strong">27:</emphasis>1755–1760.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0142" role="bibliographyEntry">
            <para>142.<emphasis role="strong">Clinical and Laboratory Standards Institute.</emphasis> 2016. <emphasis><citetitle>Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria; Approved Guideline</citetitle></emphasis>, 3rd ed. Document M45-A. Clinical and Laboratory Standards Institute, Wayne, PA.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0143" role="bibliographyEntry">
            <para>143.<emphasis role="strong">The European Committee on Antimicrobial Susceptibility Testing.</emphasis> 2022. Breakpoint tables for interpretation of MICs and zone diameters. Version 12.0. <ulink url="http://www.eucast.org/clinical">http://www.eucast.org/clinical_breakpoints/"&gt;http://www.eucast.org/clinical"&gt;http://www.eucast.org/clinical_breakpoints/</ulink>.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0144" role="bibliographyEntry">
            <para>144.<emphasis role="strong">Swenson JM, Facklam RR, Thornsberry C.</emphasis> 1990. Antimicrobial susceptibility of vancomycin-resistant <emphasis><citetitle>Leuconostoc</citetitle>, <citetitle>Pediococcus</citetitle></emphasis>, and <emphasis><citetitle>Lactobacillus</citetitle></emphasis> species. <emphasis><citetitle>Antimicrob Agents Chemother</citetitle></emphasis> <emphasis role="strong">34:</emphasis>543–549.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0145" role="bibliographyEntry">
            <para>145.<emphasis role="strong">Huang Y-T, Liao C-H, Teng L-J, Hsueh P-R.</emphasis> 2007. Daptomycin susceptibility of unusual gram-positive bacteria: comparison of results obtained by the Etest and the broth microdilution method. <emphasis><citetitle>Antimicrob Agents Chemother</citetitle></emphasis> <emphasis role="strong">51:</emphasis>1570–1572.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0146" role="bibliographyEntry">
            <para>146.<emphasis role="strong">Iwen PC, Mindru C, Kalil AC, Florescu DF.</emphasis> 2012. <emphasis><citetitle>Pediococcus acidilactici</citetitle></emphasis> endocarditis successfully treated with daptomycin. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">50:</emphasis>1106–1108.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0147" role="bibliographyEntry">
            <para>147.<emphasis role="strong">Tuohy MJ, Procop GW, Washington JA.</emphasis> 2000. Antimicrobial susceptibility of <emphasis><citetitle>Abiotrophia adiacens</citetitle></emphasis> and <emphasis><citetitle>Abiotrophia defectiva</citetitle></emphasis>. <emphasis><citetitle>Diagn Microbiol Infect Dis</citetitle></emphasis> <emphasis role="strong">38:</emphasis>189–191.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0148" role="bibliographyEntry">
            <para>148.<emphasis role="strong">Alberti MO, Hindler JA, Humphries RM.</emphasis> 2015. Antimicrobial susceptibilities of <emphasis><citetitle>Abiotrophia defectiva</citetitle>, <citetitle>Granulicatella adiacens</citetitle></emphasis>, and <emphasis><citetitle>Granulicatella elegans</citetitle></emphasis>. <emphasis><citetitle>Antimicrob Agents Chemother</citetitle></emphasis> <emphasis role="strong">60:</emphasis>1411–1420.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0149" role="bibliographyEntry">
            <para>149.<emphasis role="strong">Mushtaq A, Greenwood-Quaintance KE, Cole NC, Kohner PC, Ihde SM, Strand GJ, Harper LW, Virk A, Patel R.</emphasis> 2016. Differential antimicrobial susceptibilities of Granulicatella adiacens and Abiotrophia defectiva. <emphasis><citetitle>Antimicrob Agents Chemother</citetitle></emphasis> <emphasis role="strong">60:</emphasis>5036–5039.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0150" role="bibliographyEntry">
            <anchor id="ch0040s0018s0007a0006"/>
            <para>150.<emphasis role="strong">Prasidthrathsint K, Fisher MA.</emphasis> 2017. Antimicrobial susceptibility patterns among a large, nationwide cohort of <emphasis><citetitle>Abiotrophia</citetitle></emphasis> and <emphasis><citetitle>Granulicatella</citetitle></emphasis> clinical isolates. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">55:</emphasis>1025–1031.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0151" role="bibliographyEntry">
            <para>151.<emphasis role="strong">Alberti MO, Hindler JA, Humphries RM.</emphasis> 2016. Performance of Etest for antimicrobial susceptibility testing of <emphasis><citetitle>Abiotrophia defectiva</citetitle></emphasis> and <emphasis><citetitle>Granulicatella</citetitle></emphasis> species. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">54:</emphasis>2194–2196.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0152" role="bibliographyEntry">
            <para>152.<emphasis role="strong">Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Tleyjeh IM, Rybak MJ, Barsic B, Lockhart PB, Gewitz MH, Levison ME, Bolger AF, Steckelberg JM, Baltimore RS, Fink AM, O’Gara P, Taubert KA, American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and Stroke Council.</emphasis> 2015. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. <emphasis><citetitle>Circulation</citetitle></emphasis> <emphasis role="strong">132:</emphasis>1435–1486.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0153" role="bibliographyEntry">
            <para>153.<emphasis role="strong">Zheng X, Freeman AF, Villafranca J, Shortridge D, Beyer J, Kabat W, Dembkowski K, Shulman ST.</emphasis> 2004. Antimicrobial susceptibilities of invasive pediatric <emphasis><citetitle>Abiotrophia</citetitle></emphasis> and <emphasis><citetitle>Granulicatella</citetitle></emphasis> isolates. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">42:</emphasis>4323–4326.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0154" role="bibliographyEntry">
            <para>154.<emphasis role="strong">Piper KE, Steckelberg JM, Patel R, Patel R.</emphasis> 2005. In vitro activity of daptomycin against clinical isolates of Gram-positive bacteria. <emphasis><citetitle>J Infect Chemother</citetitle></emphasis> <emphasis role="strong">11:</emphasis>207–209.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0155" role="bibliographyEntry">
            <para>155.<emphasis role="strong">Buu-Hoï A, Le Bouguénec C, Horaud T.</emphasis> 1989. Genetic basis of antibiotic resistance in <emphasis><citetitle>Aerococcus viridans</citetitle></emphasis>. <emphasis><citetitle>Antimicrob Agents Chemother</citetitle></emphasis> <emphasis role="strong">33:</emphasis>529–534.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0156" role="bibliographyEntry">
            <para>156.<emphasis role="strong">Buu-Hoï A, Sapoetra A, Branger C, Acar JF.</emphasis> 1982. Antimicrobial susceptibility of <emphasis><citetitle>Gemella haemolysans</citetitle></emphasis> isolated from patients with subacute endocarditis. <emphasis><citetitle>Eur J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">1:</emphasis>102–106.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0157" role="bibliographyEntry">
            <para>157.<emphasis role="strong">Zolezzi PC, Cepero PG, Ruiz J, Laplana LM, Calvo CR, Gómez-Lus R.</emphasis> 2007. Molecular epidemiology of macrolide and tetracycline resistances in commensal <emphasis><citetitle>Gemella</citetitle></emphasis> sp. isolates. <emphasis><citetitle>Antimicrob Agents Chemother</citetitle></emphasis> <emphasis role="strong">51:</emphasis>1487–1490.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0158" role="bibliographyEntry">
            <para>158.<emphasis role="strong">Skov R, Christensen JJ, Korner B, Frimodt-Møller N, Espersen F.</emphasis> 2001. In vitro antimicrobial susceptibility of <emphasis><citetitle>Aerococcus urinae</citetitle></emphasis> to 14 antibiotics, and time-kill curves for penicillin, gentamicin and vancomycin. <emphasis><citetitle>J Antimicrob Chemother</citetitle></emphasis> <emphasis role="strong">48:</emphasis>653–658.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0159" role="bibliographyEntry">
            <para>159.<emphasis role="strong">Carkaci D, Nielsen XC, Fuursted K, Skov R, Skovgaard O, Trallero EP, Lienhard R, Åhman J, Matuschek E, Kahlmeter G, Christensen JJ.</emphasis> 2017. <emphasis><citetitle>Aerococcus urinae</citetitle></emphasis> and <emphasis><citetitle>Aerococcus sanguinicola</citetitle></emphasis>: susceptibility testing of 120 isolates to six antimicrobial agents using disk diffusion (EUCAST), Etest, and broth microdilution techniques. <emphasis><citetitle>Open Microbiol J</citetitle></emphasis> <emphasis role="strong">11:</emphasis>160–166.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0160" role="bibliographyEntry">
            <para>160.<emphasis role="strong">Humphries RM, Lee C, Hindler JA.</emphasis> 2011. <emphasis><citetitle>Aerococcus urinae</citetitle></emphasis> and trimethoprim-sulfamethoxazole. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">49:</emphasis>3934–3935.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0161" role="bibliographyEntry">
            <para>161.<emphasis role="strong">Guérin F, Isnard C, Bucquet F, Fines-Guyon M, Giard J-C, Burrus V, Cattoir V.</emphasis> 2016. Novel chromosome-encoded erm(<link linkend="ch0040s0018s0007li0047">47</link>) determinant responsible for constitutive MLSB resistance in <emphasis><citetitle>Helcococcus kunzii</citetitle></emphasis>. <emphasis><citetitle>J Antimicrob Chemother</citetitle></emphasis> <emphasis role="strong">71:</emphasis>3046–3049.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0162" role="bibliographyEntry">
            <para>162.<emphasis role="strong">LaClaire L, Facklam R.</emphasis> 2000. Antimicrobial susceptibilities and clinical sources of <emphasis><citetitle>Facklamia</citetitle></emphasis> species. <emphasis><citetitle>Antimicrob Agents Chemother</citetitle></emphasis> <emphasis role="strong">44:</emphasis>2130–2132.</para>
          </listitem>
          <listitem id="ch0040s0018s0007li0163" role="bibliographyEntry">
            <para>163.<emphasis role="strong">Shewmaker PL, Steigerwalt AG, Shealey L, Weyant R, Facklam RR.</emphasis> 2001. DNA relatedness, phenotypic characteristics, and antimicrobial susceptibilities of <emphasis><citetitle>Globicatella sanguinis</citetitle></emphasis> strains. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">39:</emphasis>4052–4057.</para>
          </listitem>
        </itemizedlist>
        <orderedlist role="notesList">
          <listitem role="noteEntry">
            <para>We gratefully acknowledge the contribution of Kathryn L. Ruoff to<ulink url="ch0041#ch0041s0001s0001">chapter 25</ulink> in the 12th edition of this <emphasis>Manual</emphasis>.</para>
          </listitem>
        </orderedlist>
      </sect2>
    </sect1>
  </chapter>
